<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>MedWorm: Borderline Tumor</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 7000 RSS medical sources are combined and output via different filters. This feed contains the latest news and research in the Borderline Tumor category.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%2B%28borderline+%22atypical+proliferative%22%29+%2B%28tumor%2A+tumour%2A%29&kid=155168&t=Borderline+Tumor&f=cancer]]></link>
        <lastBuildDate>Thu, 09 Feb 2012 00:50:04 +0100</lastBuildDate>
        <item>
            <title>Encapsulated papillary thyroid carcinoma, follicular variant: A misnomer</title>
            <link>http://www.medworm.com/index.php?rid=5651005&amp;cid=c_155168_32_f&amp;fid=28435&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1440-1827.2011.02773.x</link>
            <description>In conclusion, a malignant diagnosis of EnFVPTC should not be used to cover this spectrum of tumors until uncertainty about the nature of this lesion is settled, whether it is benign, precancerous or malignant. (Source: Pathology International)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Pathology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651005</comments>
            <pubDate>Mon, 30 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5651005</guid>        </item>
        <item>
            <title>MGMT promoter hypermethylation and its associations with genetic alterations in a series of 350 brain tumors</title>
            <link>http://www.medworm.com/index.php?rid=5647039&amp;cid=c_155168_6_f&amp;fid=33361&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F75027v32117t0m15%2F</link>
            <description>The objective of this study was to retrospectively investigate MGMT promoter hypermethylation status for a series of 350 human brain tumors, including 275 gliomas of different malignancy grade,
 21 glioblastoma multiforme (GBM) cell lines, and 75 non-glial tumors. The analysis was performed by methylation-specific PCR
 and capillary electrophoresis. MGMT expression at the protein level was also evaluated by both immunohistochemistry (IHC)
 and western blotting analysis. Associations of MGMT hypermethylation with IDH1/IDH2 mutations, EGFR amplification, TP53 mutations, and 1p/19q co-deletion, and the prognostic significance of these, were investigated for the gliomas. MGMT promoter hypermethylation was identified in 37.8% of gliomas, but was not present in non-glial tumors, with the excepti...</description>
            <author>Journal of Neuro-Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647039</comments>
            <pubDate>Fri, 27 Jan 2012 17:56:38 +0100</pubDate>
            <guid isPermaLink="false">5647039</guid>        </item>
        <item>
            <title>Loss of E‐cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5621971&amp;cid=c_155168_39_f&amp;fid=32038&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0463.2011.02863.x</link>
            <description>In this study, the expression of E‐cadherin was evaluated in CRC to determine its correlation with clinico‐pathological variables, and association with disease outcome in patients with long‐term follow‐up. The present series consisted of tissue samples obtained from 230 patients with stage I, II, III, or IV CRC treated during 1981–1990 at Turku University Hospital. Archival paraffin‐embedded samples were used to build up tissue microarray blocks, and E‐cadherin expression was assessed by immunohistochemistry using an automated staining system. Different grading systems were tested for expression of E‐cadherin. Fifty‐nine percent of all tumors were positive for E‐Cadherin. There was no significant correlation between E‐cadherin expression and gender (p &amp;lt; 0.83), ...</description>
            <author>APMIS</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621971</comments>
            <pubDate>Mon, 23 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5621971</guid>        </item>
        <item>
            <title>Changes in immunomodulatory constituents of human milk in response to active infection in the nursing infant.</title>
            <link>http://www.medworm.com/index.php?rid=5610689&amp;cid=c_155168_33_f&amp;fid=36864&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22258136%26dopt%3DAbstract</link>
            <description>Discussion:During active infection in nursing infants, the total number of white blood cells, specifically the number of macrophages, and TNFα levels increase in their mothers' breast milk. These results may support the dynamic nature of the immune defense provided by breastfeeding sick infants.Methods:Breast milk from mothers of 31 infants, up to 3 months of age, who were hospitalized with fever, was sampled during active illness and recovery. Milk from mothers of 20 healthy infants served as controls.
    PMID: 22258136 [PubMed - in process] (Source: Pediatric Research)</description>
            <author>Pediatric Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5610689</comments>
            <pubDate>Fri, 20 Jan 2012 23:36:12 +0100</pubDate>
            <guid isPermaLink="false">5610689</guid>        </item>
        <item>
            <title>Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy</title>
            <link>http://www.medworm.com/index.php?rid=5619653&amp;cid=c_155168_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2342xp55q2133547%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;This system describes discrete clinical subgroups of patients with pancreatic cancer who have similar, potentially resectable
 tumor anatomy but heterogeneous physiology and cancer biology. It may be used with neoadjuvant therapy to predict outcomes,
 individualize treatment algorithms, and optimize survival.
 
 
 
 
	Content Type Journal ArticleCategory Pancreatic TumorsPages 1-9DOI 10.1245/s10434-011-2211-4Authors
		Ching-Wei D. Tzeng, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAJason B. Fleming, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAJeffrey E. Lee, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAL...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5619653</comments>
            <pubDate>Thu, 19 Jan 2012 07:00:34 +0100</pubDate>
            <guid isPermaLink="false">5619653</guid>        </item>
        <item>
            <title>The value of frozen section evaluation in the management of borderline ovarian tumors</title>
            <link>http://www.medworm.com/index.php?rid=5608259&amp;cid=c_155168_6_f&amp;fid=33836&amp;url=http%3A%2F%2Fwww.cancerjournal.net%2Ftext.asp%3F2011%2F7%2F4%2F416%2F92005</link>
            <description>Conclusion: In the frozen section evaluation of BOTs, the underdiagnosis that restricts the diagnostic performance of the method seems to be a major problem. A more careful approach is therefore needed, while choosing a proper surgical technique during laparotomy for ovarian masses. In order to reduce the false diagnosis and surgical morbidity, the frozen section analysis should be applied by experienced pathologists and the possible predictive factors affecting a false diagnosis should carefully be taken into consideration. (Source: Journal of Cancer Research and Therapeutics)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Journal of Cancer Research and Therapeutics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608259</comments>
            <pubDate>Thu, 19 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5608259</guid>        </item>
        <item>
            <title>Histologic pattern, bilaterality and clinical evaluation of 957 ovarian neoplasms: A 10-year study in a tertiary hospital of eastern India</title>
            <link>http://www.medworm.com/index.php?rid=5608262&amp;cid=c_155168_6_f&amp;fid=33836&amp;url=http%3A%2F%2Fwww.cancerjournal.net%2Ftext.asp%3F2011%2F7%2F4%2F433%2F92011</link>
            <description>Conclusion: We noted an earlier age at presentation of malignant tumors. Mature teratoma was found to be the second most common benign tumor (after serous cystadenoma). We also noted a lower percentage of endometrioid tumors. Lower number of stage IV tumors was noted, with a significant number of malignant ovarian tumors presenting at an earlier age. (Source: Journal of Cancer Research and Therapeutics)</description>
            <author>Journal of Cancer Research and Therapeutics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608262</comments>
            <pubDate>Thu, 19 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5608262</guid>        </item>
        <item>
            <title>Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial</title>
            <link>http://www.medworm.com/index.php?rid=5611114&amp;cid=c_155168_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F60r78622652k1j14%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Glioblastoma (GBM) is a morphologically heterogeneous tumor type with a median survival of only 15&amp;nbsp;months in clinical trial
 populations. However, survival varies greatly among patients. As part of a central pathology review, we addressed the question
 if patients with GBM displaying distinct morphologic features respond differently to combined chemo-radiotherapy with temozolomide.
 Morphologic features were systematically recorded for 360 cases with particular focus on the presence of an oligodendroglioma-like
 component and respective correlations with outcome and relevant molecular markers. GBM with an oligodendroglioma-like component
 (GBM-O) represented 15% of all confirmed GBM (52/339) and was not associated with a more favorable outcome. GBM-O encompassed
 a...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5611114</comments>
            <pubDate>Tue, 17 Jan 2012 07:11:19 +0100</pubDate>
            <guid isPermaLink="false">5611114</guid>        </item>
        <item>
            <title>Pylorus- and spleen-preserving total pancreatoduodenectomy with resection of both whole splenic vessels: feasibility and laparoscopic application to intraductal papillary mucin-producing tumors of the pancreas</title>
            <link>http://www.medworm.com/index.php?rid=5601885&amp;cid=c_155168_43_f&amp;fid=33295&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc1506q787wt63p43%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;PpSpTPD with segmental resection of both splenic vessels is feasible and safe. Even a minimally invasive approach can be indicated
 in selected patients.
 
 
 
 
	Content Type Journal ArticleCategory Dynamic ManuscriptPages 1-6DOI 10.1007/s00464-011-2113-3Authors
		Sung Hoon Choi, Division of Hepatobiliary and Pancreas, Department of Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 120-752 KoreaHo Kyoung Hwang, Division of Hepatobiliary and Pancreas, Department of Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 120-752 KoreaChang Moo Kang, Division of Hepatobiliary and Pancreas, Department of Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 120-752 KoreaChang Ik Yoo...</description>
            <author>Surgical Endoscopy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5601885</comments>
            <pubDate>Thu, 12 Jan 2012 06:41:01 +0100</pubDate>
            <guid isPermaLink="false">5601885</guid>        </item>
        <item>
            <title>The expression of TLR pathway molecules in peripheral blood mononuclear cells and their relationship with tumor invasion and cytokine secretion in laryngeal carcinoma.</title>
            <link>http://www.medworm.com/index.php?rid=5594891&amp;cid=c_155168_61_f&amp;fid=37828&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22240197%26dopt%3DAbstract</link>
            <description>Conclusions: Our findings confirmed the implication of the TLRs pathway molecules in proinflammatory cytokine secretions and their importance as encouraging potential indicators for assessment of the degree of aggressive tumor phenotype.
    PMID: 22240197 [PubMed - as supplied by publisher] (Source: Advances in Medical Sciences)</description>
            <author>Advances in Medical Sciences</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5594891</comments>
            <pubDate>Thu, 12 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5594891</guid>        </item>
        <item>
            <title>Assessing treatment effect in pancreatic cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5560695&amp;cid=c_155168_166_f&amp;fid=36964&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22208494%26dopt%3DAbstract</link>
            <description>Conclusions.-Assessment of treatment effect in pancreatic cancer is difficult. Pathologists need to be aware that some histologic features of treatment effect overlap with histologic features seen in untreated pancreatic cancer, such as tumor cell anaplasia, necrosis, and fibrosis. Careful assessment of pancreatic resections, including detailed gross examination and thorough histologic sampling, is important in accurately assessing treatment effect and improving patient outcomes.
    PMID: 22208494 [PubMed - in process] (Source: Archives of Pathology and Laboratory Medicine)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Archives of Pathology and Laboratory Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5560695</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5560695</guid>        </item>
        <item>
            <title>The preoperative diagnosis of borderline ovarian tumors: a review of current literature</title>
            <link>http://www.medworm.com/index.php?rid=5562482&amp;cid=c_155168_29_f&amp;fid=33465&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F922u0uv644345115%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;After completion of this article, the reader should be aware of the symptoms of BOTs, the potential role and pitfalls of tumor
 marker measurement. In addition, the reader will understand the appearance of BOTs at imaging techniques; the reader will
 be able to compare and combine ultrasonography, MRI and positron emission tomography in diagnosing BOTs. In clinical practice,
 the reader should be better able to assess whether an ovarian mass is a benign tumor, a BOT or an invasive cancer.
 
 
 
 
	Content Type Journal ArticleCategory Gynecologic OncologyPages 1-10DOI 10.1007/s00404-011-2194-1Authors
		Matteo Morotti, Department of Obstetrics and Gynecology, San Martino Hospital, University of Genoa, Largo R. Benzi 1, 16132 Genoa, ItalyMario Valenzano Menada, Departmen...</description>
            <author>Archives of Gynecology and Obstetrics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5562482</comments>
            <pubDate>Fri, 30 Dec 2011 16:42:33 +0100</pubDate>
            <guid isPermaLink="false">5562482</guid>        </item>
        <item>
            <title>Immunohistochemical analysis of oral dysplasia: diagnostic assessment by fascin and podoplanin expression.</title>
            <link>http://www.medworm.com/index.php?rid=5636760&amp;cid=c_155168_60_f&amp;fid=37347&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22282584%26dopt%3DAbstract</link>
            <description>Authors: Shimamura Y, Abe T, Nakahira M, Yoda T, Murata S, Sugasawa M
    Abstract
    The aim of this study was to investigate fascin and podoplanin expression in oral dysplasia and carcinoma in situ (CIS) immunohistochemically, and to evaluate their relationship to histopathological diagnosis based on architectural and cytological features. Fascin and podoplanin expression patterns were analyzed immunohistologically in 26 specimens of oral lesions, including benign disease (hyperplasia, papilloma, and others), intraepithelial neoplasia/borderline disease (dysplasia), and malignant disease (CIS, invasive squamous cell carcinoma). Fascin expression was scored into four original categories, and podoplanin expression was scored into five previously established categories. The relationship be...</description>
            <author>Acta Histochemica et Cytochemica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5636760</comments>
            <pubDate>Wed, 28 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5636760</guid>        </item>
        <item>
            <title>CT appearance of primary peritoneal serous borderline tumour: a rare epithelial tumour of the peritoneum.</title>
            <link>http://www.medworm.com/index.php?rid=5542700&amp;cid=c_155168_37_f&amp;fid=37641&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22190758%26dopt%3DAbstract</link>
            <description>We report the CT findings of surgically proven PPSBT in which multiple peritoneal cysts were seen. Although rare, PPSBT should be considered in the differential diagnosis of primary peritoneal tumours. Since the prognosis of the disease is good, conservation of the uterus and ovaries should be a consideration in young female patients during surgery.
    PMID: 22190758 [PubMed - in process] (Source: The British Journal of Radiology)</description>
            <author>The British Journal of Radiology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5542700</comments>
            <pubDate>Mon, 26 Dec 2011 18:24:22 +0100</pubDate>
            <guid isPermaLink="false">5542700</guid>        </item>
        <item>
            <title>Imaging of hepatocellular carcinoma.</title>
            <link>http://www.medworm.com/index.php?rid=5542623&amp;cid=c_155168_37_f&amp;fid=36596&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22185702%26dopt%3DAbstract</link>
            <description>Authors: Lee JM
    Abstract
    Worldwide, hepatocellular carcinoma (HCC) is the fifth most common malignant neoplasm. The development of HCC in cirrhotic liver is described either as de novo hepatocarcinogenesis or as a multistep progression, from low-grade dysplastic nodule (DN) to high-grade DN, then to DN with microscopic foci of HCC, then to small HCC, and finally to overt carcinoma. Therefore, early detection and accurate assessment of small HCC is of great importance as the therapeutic efficacy of various treatments and the survival of patients with small HCC are much more successful than those for patients with larger tumors. The hallmark of HCC during computed tomography scan or magnetic resonance (MR) imaging is the presence of arterial enhancement followed by washout. The most ...</description>
            <author>Cancer Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5542623</comments>
            <pubDate>Mon, 26 Dec 2011 17:24:03 +0100</pubDate>
            <guid isPermaLink="false">5542623</guid>        </item>
        <item>
            <title>Analysis of the miR-34a locus in 62 patients with familial cutaneous melanoma negative for CDKN2A/CDK4 screening</title>
            <link>http://www.medworm.com/index.php?rid=5544262&amp;cid=c_155168_6_f&amp;fid=35960&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe58555g186112796%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;MicroRNAs are small non-coding RNAs, which inhibit expression of specific target genes at the post-transcriptional level and
 are often misregulated in human cancer. Among them, miR-34a is considered a tumor suppressor with a hypothetical role in melanoma tumorigenesis. In this work, 62 Italian index patients
 with familial melanoma and negative for CDKN2A/CDK4 screening were investigated for miR-34a germline mutations. Eight novel miR-34a sequence variants were identified at both the heterozygous (c.+259G&amp;gt;A, c.+424G&amp;gt;A, c.+1465C&amp;gt;T, c.+1769C&amp;gt;T, c.+2456T&amp;gt;G, c.+2603C&amp;gt;T,
 c.+2972T&amp;gt;A, c.+3069T&amp;gt;C) and homozygous (c.+424G&amp;gt;A, c.+1465C&amp;gt;T, c.+1769C&amp;gt;T) states. Molecular screening identified all nucleotide
 changes in a healthy population of 150 con...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Familial Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544262</comments>
            <pubDate>Sat, 24 Dec 2011 16:45:48 +0100</pubDate>
            <guid isPermaLink="false">5544262</guid>        </item>
        <item>
            <title>Clinicopathological features and immunoprofile of 30 cases of Brenner ovarian tumors</title>
            <link>http://www.medworm.com/index.php?rid=5545913&amp;cid=c_155168_29_f&amp;fid=33465&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk21581747j762582%2F</link>
            <description>In conclusion, Brenner ovarian tumors are unilateral, small
 and benign neoplasms in their majority and present specific histopathological and immunopathological characteristics and mixed
 forms with other epithelial and germ cell neoplasms. This could be explained as a form of metaplasia or a diverse histogenesis
 from surface epithelium and/or the germ cell ovarian component.
 
 
 
 
 
	Content Type Journal ArticleCategory Gynecologic OncologyPages 1-4DOI 10.1007/s00404-011-2182-5Authors
		A. Kondi-Pafiti, Pathology Laboratory, Aretaieion University Hospital, Athens Medical School, Athens, GreeceEvi Kairi-Vassilatou, Pathology Laboratory, Aretaieion University Hospital, Athens Medical School, Athens, GreeceCh. Iavazzo, 2nd Clinic of Obstetrics and Gynecology, Aretaieion University Hospit...</description>
            <author>Archives of Gynecology and Obstetrics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5545913</comments>
            <pubDate>Sat, 24 Dec 2011 16:41:54 +0100</pubDate>
            <guid isPermaLink="false">5545913</guid>        </item>
        <item>
            <title>Molecular pathology of pre-invasive breast disease in the screening setting: application in diagnosis and management</title>
            <link>http://www.medworm.com/index.php?rid=5630923&amp;cid=c_155168_32_f&amp;fid=38397&amp;url=http%3A%2F%2Fwww.diagnostichistopathology.co.uk%2Farticle%2FPIIS1756231711001940%2Fabstract%3Frss%3Dyes</link>
            <description>We present a review of the molecular pathology of common pre-invasive lesions of the breast particularly discussing diagnosis on needle core biopsy, their risk of progression, and clinical management following their mammographic detection. (Source: Diagnostic Histopathology)</description>
            <author>Diagnostic Histopathology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5630923</comments>
            <pubDate>Thu, 22 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5630923</guid>        </item>
        <item>
            <title>Unexpected ovarian malignancy after conservative laparoscopic surgery: five case series in a half decade of experience</title>
            <link>http://www.medworm.com/index.php?rid=5545916&amp;cid=c_155168_29_f&amp;fid=33465&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Feu77877543730318%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The main concern for laparoscopic management of ovarian masses is unexpected malignancy. However, with careful patient selection,
 proper technique and an experienced operator, laparoscopic treatment of ovarian masses is the best approach and should be
 implemented, with low risk of unexpected malignancy and recurrence.
 
 
 
 
	Content Type Journal ArticleCategory Gynecologic OncologyPages 1-4DOI 10.1007/s00404-011-2177-2Authors
		Noraziana Abd Wahab, Department of Obstetrics and Gynecology, Kulliyyah of medicine, Jalan Hospital, International Islamic University, 25710 Kuantan, Pahang, MalaysiaAmphan Chalermchockchareonkit, Department of Obstetrics and Gynecology, Thai-German Multidisciplinary Endoscopic Training Center, Faculty of Medicine Siriraj Hospital, Mahidol ...</description>
            <author>Archives of Gynecology and Obstetrics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5545916</comments>
            <pubDate>Wed, 21 Dec 2011 20:07:58 +0100</pubDate>
            <guid isPermaLink="false">5545916</guid>        </item>
        <item>
            <title>Potentially functional genetic variants in KDR gene as prognostic markers in patients with resected colorectal cancer</title>
            <link>http://www.medworm.com/index.php?rid=5524028&amp;cid=c_155168_6_f&amp;fid=31105&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1349-7006.2011.02194.x</link>
            <description>AbstractAngiogenesis plays a key role in the development and treatment response of various tumors. The signaling transductions mediated by the binding of VEGF to its receptor KDR is the most important pathway in tumor angiogenesis. Single nucleotide polymorphisms (SNPs) in VEGF have been extensively implicated in the etiology and treatment outcome of colorectal cancer (CRC). However, no study has been reported evaluating the role of KDR SNPs in CRC prognosis. We herein assessed the association between four potentially functional KDR SNPs and tumor recurrence in a Chinese population with 408 surgically resected CRC patients. The most significant SNP was for rs10013228 located in KDR gene promoter. Compared to the homozygous wild‐type genotype, the variant‐containing genotypes of this SN...</description>
            <author>Cancer Science</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524028</comments>
            <pubDate>Mon, 19 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5524028</guid>        </item>
        <item>
            <title>Cardiac surgery for carcinoid heart disease in 12 cases</title>
            <link>http://www.medworm.com/index.php?rid=5521462&amp;cid=c_155168_157_f&amp;fid=35963&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr3xl81464h102744%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Postoperative prognosis may be worse when preoperative left ventricular ejection fraction is borderline, even if it is within
 the normal limits. Cardiac evaluation is needed in all patients with carcinoid disease from the earliest time of medical and
 oncological therapy to improve patient outcome.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 780-785DOI 10.1007/s11748-010-0758-9Authors
		Satsuki Komoda, Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyTakeshi Komoda, Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyMarianne E. Pavel, Department of Internal Medicine, Division of Hepatology, Gas...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>General Thoracic and Cardiovascular Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5521462</comments>
            <pubDate>Thu, 15 Dec 2011 16:44:31 +0100</pubDate>
            <guid isPermaLink="false">5521462</guid>        </item>
        <item>
            <title>Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins</title>
            <link>http://www.medworm.com/index.php?rid=5507244&amp;cid=c_155168_32_f&amp;fid=28429&amp;url=http%3A%2F%2Fjcp.bmj.com%2Fcgi%2Fcontent%2Fshort%2F65%2F1%2F69%3Frss%3D1</link>
            <description>Conclusion
A predictive nomogram based on three histological criteria and surgical margin status can be used to calculate recurrence-free survival of an individual woman diagnosed with PT. This can be applied for patient counselling and clinical management. (Source: Journal of Clinical Pathology)</description>
            <author>Journal of Clinical Pathology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507244</comments>
            <pubDate>Tue, 13 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507244</guid>        </item>
        <item>
            <title>Overexpression of SGLT1 is correlated with tumor development and poor prognosis of ovarian carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5496354&amp;cid=c_155168_29_f&amp;fid=33465&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F05m226765235340r%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;SGLT1 overexpression, as examined by immunohistochemistry, is an independent biomarker for poor prognosis of patients with
 ovarian carcinoma.
 
 
 
 
	Content Type Journal ArticleCategory Gynecologic OncologyPages 1-7DOI 10.1007/s00404-011-2166-5Authors
		Bingquan Lai, Zhongshan School of Medicine, Sun Yat-Sen University, 74 Zhongshan Road II, Guangzhou, 510080 ChinaYongbo Xiao, Department of Pathology, Cancer Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, ChinaHongwei Pu, Department of Pathology, Xinjiang Medical University, Urumuqi, 830054 ChinaQinghua Cao, Department of Pathology, Cancer Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, ChinaHualan Jing, Zhongshan School of Medicine, Sun Yat-Sen University, 74 Zh...</description>
            <author>Archives of Gynecology and Obstetrics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5496354</comments>
            <pubDate>Fri, 09 Dec 2011 17:04:35 +0100</pubDate>
            <guid isPermaLink="false">5496354</guid>        </item>
        <item>
            <title>Good results for bowel cancer testing</title>
            <link>http://www.medworm.com/index.php?rid=5488633&amp;cid=c_155168_26_f&amp;fid=23300&amp;url=http%3A%2F%2Fwww.nhs.uk%2Fnews%2F2011%2F12December%2FPages%2Fbowel-cancer-testing-programme-examined.aspx</link>
            <description>Conclusion
This analysis of a relatively new screening programme demonstrates that the programme has been effective in detecting bowel cancers at an early stage. This is extremely important in this disease, as in the absence of an effective screening programme most cases would not be diagnosed until they have progressed considerably. At this point treatment becomes more difficult, and survival is less likely than those cases diagnosed at an early stage. 
The researchers say that uptake of the programme outside of London was very good, and high by international standards. The study also revealed unexpected variations in participation across regions and socioeconomic levels. Knowledge of such variation is essential, as it allows programme administrators to alter their recruitment and invitat...</description>
            <author>NHS News Feed</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5488633</comments>
            <pubDate>Thu, 08 Dec 2011 17:30:00 +0100</pubDate>
            <guid isPermaLink="false">5488633</guid>        </item>
        <item>
            <title>Weapons Ovarian Epithelial Tumors May Use in Immune Escape: An Immunohistochemical Correlational Study.</title>
            <link>http://www.medworm.com/index.php?rid=5502293&amp;cid=c_155168_32_f&amp;fid=28427&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22161157%26dopt%3DAbstract</link>
            <description>Authors: Hasby EA
    Abstract
    Investigate FasL and survivin expression in a series of primary ovarian surface epithelial tumors, correlate their expression with each other, and characterize the presence of CD3+ T-lymphocytes in studied tumors and determine whether their presence correlates with FasL or survivin expression in malignant cases. FasL and survivin expression was assessed in 54 ovarian epithelial tumors. The results were compared between different tumor types and grades. Correlation between both markers' expression in all studied tumors was done. Either marker's expression was compared to the mean CD3+ T-lymphocytes per HPF in the studied malignant tumors. Either FasL or survivin expression was significantly higher in malignant versus benign ovarian epithelial tumors (p &amp;...</description>
            <author>Pathology Oncology Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5502293</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5502293</guid>        </item>
        <item>
            <title>Pediatric risk of malignancy index for preoperative evaluation of childhood ovarian tumors</title>
            <link>http://www.medworm.com/index.php?rid=5490698&amp;cid=c_155168_43_f&amp;fid=33306&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F06335142001666m5%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The novel pediatric risk-of-malignancy index is able to accurately discriminate between benign and non-benign ovarian tumors
 in children and adolescents. Its preoperative application may guide surgical management decisions before the availability
 of histological confirmation.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s00383-011-3031-0Authors
		Amos Hong Pheng Loh, Department of Paediatric Surgery, KK Women’s and Children’s Hospital, 100 Bukit Timah Road, Singapore, 229899 SingaporeChiou Li Ong, Department of Diagnostic and Interventional Imaging, KK Women’s and Children’s Hospital, Singapore, SingaporeShu Lin Lam, Department of Diagnostic and Interventional Imaging, KK Women’s and Children’s Hospital, Singapore, S...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Pediatric Surgery International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5490698</comments>
            <pubDate>Wed, 07 Dec 2011 12:54:42 +0100</pubDate>
            <guid isPermaLink="false">5490698</guid>        </item>
        <item>
            <title>Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes</title>
            <link>http://www.medworm.com/index.php?rid=5486434&amp;cid=c_155168_6_f&amp;fid=33343&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fkt45636704677606%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;These results suggest that common genetic variations in these pathways may modulate risk and clinical outcomes of endometrial
 cancer. Further replication and functional studies are needed to confirm these findings.
 
 
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-9DOI 10.1007/s00432-011-1103-0Authors
		Li-E Wang, Department of Epidemiology, Unit 1365, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USAHongxia Ma, Department of Epidemiology, Unit 1365, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USAKatherine S. Hale, Department of Systems Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USAMing Yin, Department of Epidemiology, U...</description>
            <author>Journal of Cancer Research and Clinical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486434</comments>
            <pubDate>Tue, 06 Dec 2011 17:01:19 +0100</pubDate>
            <guid isPermaLink="false">5486434</guid>        </item>
        <item>
            <title>Comparative study of histological features between core needle biopsy and surgical excision in phyllodes tumor</title>
            <link>http://www.medworm.com/index.php?rid=5478647&amp;cid=c_155168_32_f&amp;fid=28435&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1440-1827.2011.02761.x</link>
            <description>We analyzed histopathological features of core needle biopsy (CNB) and surgical excision specimen comparatively in 129 patients with surgically proven phyllodes tumor (PT). Stromal characteristics including cellularity, atypia, mitosis, overgrowth, tissue fragmentation, and the tumor margin were assessed. Benign/borderline/malignant phyllodes tumor (PT) were diagnosed in 90 (69.8%)/30 (23.3%)/9 (7.0%) patients. Among the 90 cases of benign PTs, 67 cases (74.4%) were diagnosed concordantly in CNB. For borderline and malignant PTs, three out of eight (26.6%) and four out of nine (44.4%) cases were diagnosed concordantly in CNBs. All 50 cases of discordant diagnosis were underestimated in matched CNBs, especially in their stromal cellularity and mitosis. The size of tumor is larger in discord...</description>
            <author>Pathology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5478647</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5478647</guid>        </item>
        <item>
            <title>Significance of epidermal growth factor receptor expression in the grading of phyllodes tumors of the breast</title>
            <link>http://www.medworm.com/index.php?rid=5507291&amp;cid=c_155168_32_f&amp;fid=37713&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1755-9294.2011.01116.x</link>
            <description>Conclusions: Epidermal growth factor receptor overexpression, more than 10% of tumor cells, could be used as an ancillary tool for the discrimination of benign from borderline and malignant PTs. (Source: Basic and Applied Pathology)</description>
            <author>Basic and Applied Pathology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507291</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5507291</guid>        </item>
        <item>
            <title>Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival</title>
            <link>http://www.medworm.com/index.php?rid=5516626&amp;cid=c_155168_32_f&amp;fid=28438&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2559.2011.04045.x</link>
            <description>Conclusions:  Our findings suggest that Dock180 contributes to ovarian carcinogenesis and dissemination and is a potential prognostic marker and therapeutic target. (Source: Histopathology)</description>
            <author>Histopathology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516626</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5516626</guid>        </item>
        <item>
            <title>Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study</title>
            <link>http://www.medworm.com/index.php?rid=5451303&amp;cid=c_155168_37_f&amp;fid=33428&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fdv5452rgj0216811%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Quantitative DCE-MRI is a feasible and accurate technique to differentiate malignant from benign adnexal tumours and could
 potentially help oncologists with management decisions.
 
 
 
 
 Key Points&amp;nbsp;&amp;nbsp;• Quantitative DCE MR imaging allows accurate differentiation between malignant and benign tumours
 
 
 
 • Quantitative DCE MRI may help predict peritoneal carcinomatosis associated with ovarian tumors
 
 
 
 
 • Quantitative DCE MRI helps distinguish between invasive and borderline primary ovarian tumours
 
 
 
 
 
 
	Content Type Journal ArticleCategory UrogenitalPages 1-8DOI 10.1007/s00330-011-2329-6Authors
		Isabelle Thomassin-Naggara, Department of Radiology, Hôpital Tenon, Assistance Publique–Hôpitaux de Paris, Paris, FranceDaniel Balvay, Labor...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>European Radiology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5451303</comments>
            <pubDate>Tue, 22 Nov 2011 06:55:35 +0100</pubDate>
            <guid isPermaLink="false">5451303</guid>        </item>
        <item>
            <title>Clinical Significance of IEX-1 Expression in Ovarian Carcinoma.</title>
            <link>http://www.medworm.com/index.php?rid=5430857&amp;cid=c_155168_32_f&amp;fid=28425&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22085302%26dopt%3DAbstract</link>
            <description>Conclusion: With the development of epithelial ovarian tumors from benign to malignant, IEX-1 expression is decreased, concomitant with a decreased rate of cell apoptosis. Thus, IEX-1 is pro-apoptotic in the development of epithelial ovarian cancer. The pro-apoptotic activity may take part in restraining tumor growth at the early stage of ovarian epithelial cancer, whereas its decreased expression probably contributes to the abnormal survival advantage for malignant cancer. Altered IEX-1 expression can potentially be a new predictor of the malignant transformation and a prognostic indicator for cancer therapy.
    PMID: 22085302 [PubMed - in process] (Source: Ultrastructural Pathology)</description>
            <author>Ultrastructural Pathology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5430857</comments>
            <pubDate>Mon, 21 Nov 2011 20:36:21 +0100</pubDate>
            <guid isPermaLink="false">5430857</guid>        </item>
        <item>
            <title>Low‐grade serous carcinomas of the ovary contain very few point mutations</title>
            <link>http://www.medworm.com/index.php?rid=5433473&amp;cid=c_155168_32_f&amp;fid=33653&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fpath.3967</link>
            <description>AbstractIt has been well established that ovarian low‐grade and high‐grade serous carcinomas are fundamentally different types of tumours. While the molecular genetic features of ovarian high‐grade serous carcinomas are now well known, the pathogenesis of low‐grade serous carcinomas, apart from the recognition of frequent somatic mutations involving KRAS and BRAF, is largely unknown. In order to comprehensively analyze somatic mutations in low‐grade serous carcinomas, we applied exome sequencing to the DNA of eight samples of affinity‐purified low‐grade serous carcinomas. A remarkably small number of mutations were identified in seven of these tumours: a total of 70 somatic mutations in 64 genes. The eighth case displayed mixed serous and endometrioid features and a mutator p...</description>
            <author>The Journal of Pathology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5433473</comments>
            <pubDate>Mon, 21 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5433473</guid>        </item>
        <item>
            <title>Solid tumors in Turkish children: a multicenter study.</title>
            <link>http://www.medworm.com/index.php?rid=5448694&amp;cid=c_155168_33_f&amp;fid=38031&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22105573%26dopt%3DAbstract</link>
            <description>CONCLUSIONS:            We conclude that the cancer patterns of children in the Ankara region mostly resemble with those of the western population. This study provides useful information on the diagnosis of solid tumors in children and highlights variations in cancer incidence in different age groups.
    PMID: 22105573 [PubMed - as supplied by publisher] (Source: World Journal of Pediatrics : WJP)</description>
            <author>World Journal of Pediatrics : WJP</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5448694</comments>
            <pubDate>Mon, 21 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5448694</guid>        </item>
        <item>
            <title>Effectiveness of semi-quantitative multiphase dynamic contrast-enhanced MRI as a predictor of malignancy in complex adnexal masses: radiological and pathological correlation</title>
            <link>http://www.medworm.com/index.php?rid=5433925&amp;cid=c_155168_37_f&amp;fid=33428&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fku28816551332334%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Threshold criteria using semi-quantitative multiphase DCE-MRI&amp;nbsp;improves specificity in the prediction of malignancy in complex
 adnexal masses with enhancing components and is complementary to standard qualitative assessment.
 
 
 
 
 
 Key Points
 &amp;nbsp;&amp;nbsp;• Semi-quantitative DCE-MRI threshold criteria are effective for predicting ovarian malignancy
 
 
 
 • The surgical approach may be altered depending on DCE-MRI threshold criteria analysis
 
 
 
 
 • Borderline tumours demonstrate significant overlap with benign lesions using DCE-MRI threshold criteria
 
 
 
 
 
 
	Content Type Journal ArticleCategory Magnetic ResonancePages 1-11DOI 10.1007/s00330-011-2331-zAuthors
		Livia Bernardin, Policlinico GB Rossi, P.le L.A. Scuro, 37134 Verona, ItalyPhilip Dil...</description>
            <author>European Radiology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5433925</comments>
            <pubDate>Fri, 18 Nov 2011 06:55:03 +0100</pubDate>
            <guid isPermaLink="false">5433925</guid>        </item>
        <item>
            <title>Surgical intervention strategies for pediatric ovarian tumors: experience with 60 cases at one institution</title>
            <link>http://www.medworm.com/index.php?rid=5426191&amp;cid=c_155168_43_f&amp;fid=33306&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy84355406n38310l%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The majority of pediatric ovarian tumors were benign disease, and the patients with malignant lesions had a good prognosis.
 In neonatal cases, an umbilical crease incision approach is feasible and provides excellent cosmesis. We recommend tumor resection
 with ovarian preservation through a minimally invasive approach (modified Rocky Davis incision) as the first line treatment
 for older pediatric patients with ovarian tumors other than those preoperatively diagnosed as malignant.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-5DOI 10.1007/s00383-011-3004-3Authors
		Tatsuro Tajiri, Department of Pediatric Surgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582 JapanRyota Souzaki, Departmen...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Pediatric Surgery International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5426191</comments>
            <pubDate>Wed, 16 Nov 2011 18:00:12 +0100</pubDate>
            <guid isPermaLink="false">5426191</guid>        </item>
        <item>
            <title>Laparoscopic versus open distal pancreatectomy: a systematic review of comparative studies</title>
            <link>http://www.medworm.com/index.php?rid=5426187&amp;cid=c_155168_43_f&amp;fid=33295&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F56q70xr193l46453%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The laparoscopic approach to DP offers advantages over open surgery with lower operative morbidity, higher spleen preservation
 rate, and shorter hospital stay; these benefits are particularly observed in patients with benign disease and borderline malignancy.
 The experience with laparoscopic DP for malignant disease remains limited, and long-term follow-up data are required to clearly
 define this role.
 
 
 
 
	Content Type Journal ArticleCategory ReviewPages 1-10DOI 10.1007/s00464-011-2016-3Authors
		Asri C. Jusoh, Department of Hepato-Pancreato-Biliary Surgery, North Manchester General Hospital, Delaunays Road, Crumpsall, Manchester M8 5RB, UKBasil J. Ammori, Department of Hepato-Pancreato-Biliary Surgery, North Manchester General Hospital, Delaunays Road, Crump...</description>
            <author>Surgical Endoscopy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5426187</comments>
            <pubDate>Tue, 15 Nov 2011 06:46:48 +0100</pubDate>
            <guid isPermaLink="false">5426187</guid>        </item>
        <item>
            <title>Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort</title>
            <link>http://www.medworm.com/index.php?rid=5394877&amp;cid=c_155168_56_f&amp;fid=29383&amp;url=http%3A%2F%2Fhumrep.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F26%2F12%2F3456%3Frss%3D1</link>
            <description>CONCLUSIONS
Ovarian stimulation for IVF may increase the risk of ovarian malignancies, especially borderline ovarian tumours. More large cohort studies are needed to confirm these findings and to examine the effect of IVF treatment characteristics. (Source: Human Reproduction)</description>
            <author>Human Reproduction</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5394877</comments>
            <pubDate>Thu, 10 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5394877</guid>        </item>
        <item>
            <title>Laparoscopic management of large ovarian tumors: Clinical tips for overcoming common concerns</title>
            <link>http://www.medworm.com/index.php?rid=5390554&amp;cid=c_155168_29_f&amp;fid=32404&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1447-0756.2011.01685.x</link>
            <description>Conclusion:  Laparoscopic management of large ovarian tumors is feasible and efficient with appropriate patient selection and experience of surgeons. (Source: Journal of Obstetrics and Gynaecology Research)</description>
            <author>Journal of Obstetrics and Gynaecology Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5390554</comments>
            <pubDate>Wed, 09 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5390554</guid>        </item>
        <item>
            <title>Chromosome 17 centromere (CEP17) duplication as a predictor of anthracycline response: evidence from the NCIC Clinical Trials Group (NCIC CTG) MA.5 Trial</title>
            <link>http://www.medworm.com/index.php?rid=5384604&amp;cid=c_155168_6_f&amp;fid=33460&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fru50wxu8078qw432%2F</link>
            <description>This study suggests that
 CEP17 duplication has a borderline association with clinical responsiveness to anthracycline containing chemotherapy similar
 to previous results seen with HER2 amplification and TOP2A alteration in MA.5. An appropriately powered meta-analysis is required to discriminate the predictive value of these three
 candidate markers.
 
 
	Content Type Journal ArticleCategory Clinical trialPages 1-11DOI 10.1007/s10549-011-1840-4Authors
		Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, The University of Toronto, 2075 Bayview Avenue, Toronto, ON M4N 3M5, CanadaAlison Munro, Endocrine Cancer Group, Edinburgh Cancer Research Centre, Western General Hospital, Crewe Road South, Edinburgh, EH4 2XR UKFrances P. O’Malley, University of Toronto, Toronto, ON, CanadaDongshen...</description>
            <author>Breast Cancer Research and Treatment</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5384604</comments>
            <pubDate>Mon, 31 Oct 2011 16:52:57 +0100</pubDate>
            <guid isPermaLink="false">5384604</guid>        </item>
        <item>
            <title>Hormone therapy and ovarian borderline tumors: a national cohort study</title>
            <link>http://www.medworm.com/index.php?rid=5360048&amp;cid=c_155168_6_f&amp;fid=35914&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7777370872tupp67%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Combined hormone therapy for more than 4&amp;nbsp;years increases the risk of ovarian borderline tumors.
 
 
 
	Content Type Journal ArticleCategory Original paperPages 1-8DOI 10.1007/s10552-011-9860-2Authors
		Lina Steinrud Mørch, Gynaecological Clinic, Copenhagen University Hospital, Copenhagen University, Section 3341, Blegdamsvej 9, 2100 Copenhagen, DenmarkEllen Løkkegaard, Gynaecological-obstetrical Department, Hillerød Hospital, Copenhagen University, Hillerød, DenmarkAnne Helms Andreasen, Research Centre for Prevention and Health, The Capital Region of Denmark, Glostrup, DenmarkSusanne Krüger Kjær, Gynaecological Clinic, Copenhagen University Hospital, Copenhagen University, Section 3341, Blegdamsvej 9, 2100 Copenhagen, DenmarkØjvind Lidegaard, Gynaecolog...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Cancer Causes and Control</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5360048</comments>
            <pubDate>Fri, 28 Oct 2011 17:13:18 +0100</pubDate>
            <guid isPermaLink="false">5360048</guid>        </item>
        <item>
            <title>NHS Choices assessment of press reports about ovarian cancer risk from IVF</title>
            <link>http://www.medworm.com/index.php?rid=5360829&amp;cid=c_155168_13_f&amp;fid=38936&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FNews%2F2011---October%2F28%2FNHS-Choices-assessment-of-press-reports-about-ovarian-cancer-risk-from-IVF%2F</link>
            <description>Source: NHS Choices
Area: News
 NHS Choices has assessed a report in the Daily Telegraph that in vitro fertilisation (IVF) doubles the risk of non-fatal ovarian cancer. 
 &amp;#160; 
 The report is based on a large, long-term Dutch cohort study that examined the risk of ovarian cancer associated with IVF treatment. Its findings were published in 'Human Reproduction.' The study compared the risk of developing ovarian cancer in the 15 years following treatment with the risks of cancer in the general population and in women who had difficulty conceiving but did not undergo IVF treatment. The researchers found that the IVF group was over four-times as likely to have developed borderline ovarian tumours (not yet cancerous) compared to the non-IVF group. However, they were at no greater risk of deve...</description>
            <author>NeLM - News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5360829</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5360829</guid>        </item>
        <item>
            <title>IVF May Raise Risk for Less Aggressive Ovarian Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5361985&amp;cid=c_155168_26_f&amp;fid=23284&amp;url=http%3A%2F%2Fwww.m.webmd.com%2Fa-to-z-guides%2Fnews%2F20111027%2Fivf-may-raise-risk-for-less-aggressive-ovarian-cancer%3Fsrc%3DRSS_PUBLIC</link>
            <description>Women who undergo ovarian stimulation as part of IVF (in vitro fertilization) treatment may be more likely to develop &quot;borderline&quot; ovarian tumors, but not invasive ovarian tumors, later in life, Dutch researchers report. (Source: WebMD Health)</description>
            <author>WebMD Health</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5361985</comments>
            <pubDate>Thu, 27 Oct 2011 21:33:43 +0100</pubDate>
            <guid isPermaLink="false">5361985</guid>        </item>
        <item>
            <title>Ovarian cancer tied to fertility treatments: Cause for alarm?</title>
            <link>http://www.medworm.com/index.php?rid=5353966&amp;cid=c_155168_26_f&amp;fid=37982&amp;url=http%3A%2F%2Ffeeds.cbsnews.com%2F%7Er%2FCBSNewsHealth%2F%7E3%2FJWefSjFnYP0%2F</link>
            <description>Study found &quot;unusually high&quot; number of borderline ovarian tumors (Source: Health News: CBSNews.com)</description>
            <author>Health News: CBSNews.com</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5353966</comments>
            <pubDate>Thu, 27 Oct 2011 19:31:53 +0100</pubDate>
            <guid isPermaLink="false">5353966</guid>        </item>
        <item>
            <title>Ovary cancer risk from IVF is small</title>
            <link>http://www.medworm.com/index.php?rid=5365721&amp;cid=c_155168_26_f&amp;fid=23300&amp;url=http%3A%2F%2Fwww.nhs.uk%2Fnews%2F2011%2F10October%2FPages%2Fovarian-cancer-risk-ivf.aspx</link>
            <description>Conclusion
This was a large, long-term cohort study that examined the association between ovarian stimulation during fertility treatment and the subsequent risk of developing ovarian cancer. The study was well designed, especially in terms of its selection of an appropriate comparator group and its attempts to account for potential confounders.
In their attempt to control potential confounders the researchers collected information on baseline ovarian cancer risk through a mailed questionnaire, and on treatment factors through medical record examination. 
However, data on factors such as family history of cancer, number of pregnancies, use of birth control and lifestyle characteristics were available in only 65.2% of the total cohort. This may bias the results, as there is no way of telling...</description>
            <author>NHS News Feed</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365721</comments>
            <pubDate>Thu, 27 Oct 2011 18:05:00 +0100</pubDate>
            <guid isPermaLink="false">5365721</guid>        </item>
        <item>
            <title>IVF May Be Tied To Ovarian Tumors Later In Life</title>
            <link>http://www.medworm.com/index.php?rid=5353899&amp;cid=c_155168_26_f&amp;fid=23292&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2Furyg5gyhJFQ%2F236677.php</link>
            <description>A Dutch study suggests that stimulating the ovaries to produce eggs for in vitro fertilization or IVF, may increase the risk of developing ovarian tumors, some of which may become cancerous, later in life. Overall, the researchers found rates of non-fatal &quot;borderline ovarian tumors&quot; were increased four-fold and rates of malignant tumors were increased two-fold compared to other women seeking fertility treatment who did not undergo IVF... (Source: Health News from Medical News Today)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Health News from Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5353899</comments>
            <pubDate>Thu, 27 Oct 2011 16:00:00 +0100</pubDate>
            <guid isPermaLink="false">5353899</guid>        </item>
        <item>
            <title>IVF May Raise Risk for Less Aggressive Ovarian Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5354056&amp;cid=c_155168_26_f&amp;fid=23284&amp;url=http%3A%2F%2Fwww.webmd.com%2Finfertility-and-reproduction%2Fnews%2F20111027%2Fivf-may-raise-risk-for-less-aggressive-ovarian-cancer%3Fsrc%3DRSS_PUBLIC</link>
            <description>Women who undergo ovarian stimulation as part of IVF (in vitro fertilization) treatment may be more likely to develop &quot;borderline&quot; ovarian tumors, but not invasive ovarian tumors, later in life, Dutch researchers report. (Source: WebMD Health)</description>
            <author>WebMD Health</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5354056</comments>
            <pubDate>Thu, 27 Oct 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5354056</guid>        </item>
        <item>
            <title>Ovarian stimulation for IVF boosts risk of ovarian tumours</title>
            <link>http://www.medworm.com/index.php?rid=5353177&amp;cid=c_155168_45_f&amp;fid=20261&amp;url=http%3A%2F%2Fwww.onmedica.com%2FnewsArticle.aspx%3Fid%3Dff1b1ab3-ffac-4f01-9675-4db96f20d5e0</link>
            <description>Risk highest for borderline ovarian tumours 15 + years after treatmentRelated items from OnMedicaContraceptive pill almost halves ovarian cancer riskVaginal radiotherapy better option for cancerConsultation opens on ovarian cancer guidanceOne or two doses of HPV jab may be enoughBenefit of Herceptin in more breast cancer cases (Source: OnMedica Latest News)</description>
            <author>OnMedica Latest News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5353177</comments>
            <pubDate>Thu, 27 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5353177</guid>        </item>
        <item>
            <title>Fertility treatment raises tumor risk in study</title>
            <link>http://www.medworm.com/index.php?rid=5349573&amp;cid=c_155168_26_f&amp;fid=23271&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Freuters%2FhealthNews%2F%7E3%2F-yIC__fiRVc%2Fus-ivf-tumours-idUSTRE79P8EP20111026</link>
            <description>LONDON (Reuters) - Women given drugs during fertility treatment to stimulate their ovaries to produce extra eggs have an increased risk of developing borderline ovarian tumors, Dutch researchers said on Thursday. (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5349573</comments>
            <pubDate>Wed, 26 Oct 2011 23:14:53 +0100</pubDate>
            <guid isPermaLink="false">5349573</guid>        </item>
        <item>
            <title>Fertility Treatment Raises Tumor Risk in Study</title>
            <link>http://www.medworm.com/index.php?rid=5353439&amp;cid=c_155168_26_f&amp;fid=37163&amp;url=http%3A%2F%2Fwww.nlm.nih.gov%2Fmedlineplus%2Fnews%2Ffullstory_118008.html</link>
            <description>Women given drugs during fertility treatment to stimulate their ovaries to produce extra eggs have an increased risk of developing borderline ovarian tumors, Dutch researchers said on Thursday.Source: Reuters Health
Related MedlinePlus Pages: Female Infertility, Ovarian Cancer, Ovarian Disorders (Source: MedlinePlus Health News)</description>
            <author>MedlinePlus Health News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5353439</comments>
            <pubDate>Wed, 26 Oct 2011 22:14:53 +0100</pubDate>
            <guid isPermaLink="false">5353439</guid>        </item>
        <item>
            <title>Ovarian stimulation for IVF treatment increases risk of borderline ovarian tumors later in life</title>
            <link>http://www.medworm.com/index.php?rid=5349561&amp;cid=c_155168_46_f&amp;fid=31012&amp;url=http%3A%2F%2Fwww.eurekalert.org%2Fpub_releases%2F2011-10%2Fesoh-osf102411.php</link>
            <description>(European Society of Human Reproduction and Embryology) New research from The Netherlands has shown that sub-fertile women whose ovaries are stimulated into producing extra eggs for in-vitro fertilization have an increased risk of ovarian malignancies, in particular borderline ovarian tumors, later in life. (Source: EurekAlert! - Social and Behavioral Science)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>EurekAlert! - Social and Behavioral Science</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5349561</comments>
            <pubDate>Wed, 26 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5349561</guid>        </item>
        <item>
            <title>Survival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression</title>
            <link>http://www.medworm.com/index.php?rid=5346946&amp;cid=c_155168_6_f&amp;fid=33637&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fijc.27317</link>
            <description>AbstractCXCL12 is a chemotactic cytokine that has pro‐metastatic functions in several malignancies through interactions with its receptor, CXCR4. CXCL12 is an estrogen‐regulated gene, and notably, estrogen is a major risk factor for endometrial cancer (EC) development. As few studies examine concurrent CXCL12, CXCR4, and estrogen receptor (ER) expression in EC patients, we examined this pathway in 199 EC patients with data from the University of Pittsburgh Medical Center Cancer Registry. Immunohistochemistry (IHC) was used to detect CXCR4, CXCL12, and ER protein expression. As CXCR4 expression was positive in all cases, this investigation focused on associations between CXCL12 and ER expression, clinicopathologic factors, and survival outcomes using chi‐square tests, Kaplan‐Meier g...</description>
            <author>International Journal of Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5346946</comments>
            <pubDate>Tue, 25 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5346946</guid>        </item>
        <item>
            <title>Leak-proof extracorporeal drainage for management of large ovarian tumors</title>
            <link>http://www.medworm.com/index.php?rid=5350097&amp;cid=c_155168_29_f&amp;fid=33465&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv134384673153v3h%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Minilaparotomy with leak-proof extracorporeal drainage using cyanoacrylate adhesive and polyurethane membrane is reliable,
 safe, and feasible for management of large ovarian tumors with low probability of malignancy in selected patients.
 
 
 
 
	Content Type Journal ArticleCategory General GynecologyPages 1-4DOI 10.1007/s00404-011-2115-3Authors
		Shih-Shien Weng, Department of Obstetrics and Gynecology, Mackay Memorial Hospital, 92, Sect. 2, Chung-Shan North Road, Taipei, 10449 TaiwanYeou-Lih Wang, Department of Obstetrics and Gynecology, Mackay Memorial Hospital, 92, Sect. 2, Chung-Shan North Road, Taipei, 10449 Taiwan
	

	
		Journal Archives of Gynecology and ObstetricsOnline ISSN 1432-0711Print ISSN 0932-0067 (Source: Archives of Gynecology and Obstetrics)</description>
            <author>Archives of Gynecology and Obstetrics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5350097</comments>
            <pubDate>Fri, 21 Oct 2011 16:00:26 +0100</pubDate>
            <guid isPermaLink="false">5350097</guid>        </item>
        <item>
            <title>A case of ovarian mucinous adenocarcinoma in a premenarcheal girl</title>
            <link>http://www.medworm.com/index.php?rid=5346888&amp;cid=c_155168_6_f&amp;fid=33383&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy7m136732u21544g%2F</link>
            <description>We report a case of a 12-year-old premenarcheal girl who developed ovarian mucinous adenocarcinoma. The tumor, which originated
 from the right ovary, weighed 1400&amp;nbsp;g, and had a smooth surface and thin capsule, was extirpated. The cut surface showed multilocular
 cysts of various sizes and yellowish gelatinous to solid parts that accounted for approximately 40% of the cut surface. The
 histological findings showed a continuous mixture of mucinous adenoma, mucinous borderline tumor, and mucinous adenocarcinoma
 with an expansile invasive pattern. It was assumed that an ovarian mass developed in an early period after birth or infancy,
 and the mutation of certain oncogens occurred in an early period, leading to cancer. While some etiological hypotheses concerning
 ovarian carcinogenesis ...</description>
            <author>International Journal of Clinical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5346888</comments>
            <pubDate>Fri, 21 Oct 2011 05:55:13 +0100</pubDate>
            <guid isPermaLink="false">5346888</guid>        </item>
        <item>
            <title>Long‐term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer</title>
            <link>http://www.medworm.com/index.php?rid=5335183&amp;cid=c_155168_6_f&amp;fid=33593&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fcncr.26633</link>
            <description>CONCLUSIONS:Gemcitabine‐based neoadjuvant chemotherapy confers a significant OS advantage by allowing the selection of patients who will derive greatest benefit from CRT. Median survival with this approach was similar to that seen with surgical resection. Cancer 2011. © 2011 American Cancer Society. (Source: Cancer)</description>
            <author>Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5335183</comments>
            <pubDate>Fri, 21 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5335183</guid>        </item>
        <item>
            <title>Sporadic desmoid tumors of the chest: long-term follow-up of 28 multimodally treated patients [Original articles]</title>
            <link>http://www.medworm.com/index.php?rid=5332375&amp;cid=c_155168_157_f&amp;fid=29160&amp;url=http%3A%2F%2Fejcts.ctsnetjournals.org%2Fcgi%2Fcontent%2Fshort%2F40%2F5%2F1170%3Frss%3D1</link>
            <description>Conclusions: Because the radicality of the first surgical resection is of essential importance for long-time local control of chest desmoids, accurate preoperative diagnostics and well-planned aggressive surgical resection of the primary tumor is recommended. Due to the low incidence of desmoids, multicentric randomized investigations would be mandatory to establish evidence-based protocol for desmoid tumors. (Source: European Journal of Cardio-Thoracic Surgery)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>European Journal of Cardio-Thoracic Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5332375</comments>
            <pubDate>Thu, 20 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5332375</guid>        </item>
        <item>
            <title>Phyllodes Tumor of the Breast: Role of CD10 in Predicting Metastasis</title>
            <link>http://www.medworm.com/index.php?rid=5335130&amp;cid=c_155168_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn0w20764132g8k1q%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The expression of CD10 can be used to predict the occurrence of distant metastasis in phyllodes tumors of the breast.
 
 
 
	Content Type Journal ArticleCategory Breast OncologyPages 1-4DOI 10.1245/s10434-011-2076-6Authors
		Mahmoud Al-Masri, Department of Surgical Oncology, King Hussein Cancer Center, Amman, JordanGhaleb Darwazeh, Department of Surgical Oncology, King Hussein Cancer Center, Amman, JordanSamer Sawalhi, Department of Surgical Oncology, King Hussein Cancer Center, Amman, JordanAyman Mughrabi, Department of Surgical Oncology, King Hussein Cancer Center, Amman, JordanMaher Sughayer, Department of Pathology, King Hussein Cancer Center, Amman, JordanMarwa Al-Shatti, Department of Pathology, King Hussein Cancer Center, Amman, Jordan
	

	
		Journal Annals of...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5335130</comments>
            <pubDate>Tue, 18 Oct 2011 05:47:27 +0100</pubDate>
            <guid isPermaLink="false">5335130</guid>        </item>
        <item>
            <title>Malignant Transformation of a Serous Borderline Tumor and Early Metastasis of Associated Low-Grade Serous Carcinoma Detected on Screening Mammography [DIAGNOSIS IN ONCOLOGY]</title>
            <link>http://www.medworm.com/index.php?rid=5335058&amp;cid=c_155168_6_f&amp;fid=31124&amp;url=http%3A%2F%2Fjco.ascopubs.org%2Fcgi%2Fcontent%2Fshort%2F29%2F30%2Fe763%3Frss%3D1</link>
            <description>(Source: Journal of Clinical Oncology)</description>
            <author>Journal of Clinical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5335058</comments>
            <pubDate>Tue, 18 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5335058</guid>        </item>
        <item>
            <title>Comparative Effectiveness of Digital Versus Film-Screen Mammography in Community Practice in the United States: A Cohort Study.</title>
            <link>http://www.medworm.com/index.php?rid=5372491&amp;cid=c_155168_49_f&amp;fid=28856&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22007043%26dopt%3DAbstract</link>
            <description>Conclusion: Overall, cancer detection with digital or film-screen mammography is similar in U.S. women aged 50 to 79 years undergoing screening mammography. Women aged 40 to 49 years are more likely to have extremely dense breasts and estrogen receptor-negative tumors; if they are offered mammography screening, they may choose to undergo digital mammography to optimize cancer detection. Primary Funding Source: National Cancer Institute.
    PMID: 22007043 [PubMed - as supplied by publisher] (Source: Annals of Internal Medicine)</description>
            <author>Annals of Internal Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5372491</comments>
            <pubDate>Tue, 18 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5372491</guid>        </item>
        <item>
            <title>Adrenocortical tumors in children: imaging adenomas and carcinomas.</title>
            <link>http://www.medworm.com/index.php?rid=5354071&amp;cid=c_155168_37_f&amp;fid=36279&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22014330%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Adrenocortical tumors are rare in children. Adrenocortical tumors include adenomas and carcinomas, and in the absence of vascular infiltration and/or metastases it is difficult to differentiate between the two types by imaging and histology. The combination of an adrenal mass and clinical signs of adrenocortical hyperfunction in a child is virtually diagnostic of an adrenocortical tumor.
    PMID: 22014330 [PubMed - as supplied by publisher] (Source: Radiologia)</description>
            <author>Radiologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5354071</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5354071</guid>        </item>
        <item>
            <title>Node-negative T1–T2 anal cancer: Radiotherapy alone or concomitant chemoradiotherapy?</title>
            <link>http://www.medworm.com/index.php?rid=5539994&amp;cid=c_155168_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS016781401100541X%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: In the management of node negative T1–T2 anal cancer, LRC and CSS tend to be superior in patients treated by combined CRT, even though the difference was not significant. Randomized studies are warranted to assess definitively the role of combined treatment in early-stage anal carcinoma. (Source: Radiotherapy and Oncology)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539994</comments>
            <pubDate>Thu, 13 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5539994</guid>        </item>
        <item>
            <title>Management of non metastatic phyllodes tumors of the breast: Review of the literature</title>
            <link>http://www.medworm.com/index.php?rid=5308804&amp;cid=c_155168_43_f&amp;fid=36257&amp;url=http%3A%2F%2Fwww.so-online.net%2Farticle%2FPIIS0960740411000387%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Phyllodes tumors of the breast are rare tumors, accounting for less than 0.5% of all breast tumors. These tumors are comprised of both stromal and epithelial elements; and traditionally they are graded by the use of a set of histologic features into benign, borderline, and malignant subtypes. Unfortunately, the histologic classification of phyllodes tumors does not reliably predict clinical behavior.The mainstay of treatment of non metastatic phyllodes tumors of the breast is complete surgical resection with wide resection margins. Lumpectomy or partial mastectomy is the preferred surgical therapy. However, despite the complete surgical resection, local failure rate may be high; and 22% of malignant tumors may give rise to haematogenous metastases. The most frequent site of dista...</description>
            <author>Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5308804</comments>
            <pubDate>Thu, 13 Oct 2011 00:45:02 +0100</pubDate>
            <guid isPermaLink="false">5308804</guid>        </item>
        <item>
            <title>Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5317181&amp;cid=c_155168_29_f&amp;fid=32400&amp;url=http%3A%2F%2Fhumupd.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F17%2F6%2F741%3Frss%3D1</link>
            <description>CONCLUSIONS
Women with PCOS have increased serum concentrations of CVD risk markers compared with controls. Whether this apparent risk is translated into increased incidence of CVD in later life remains to be elucidated. (Source: Human Reproduction Update)</description>
            <author>Human Reproduction Update</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317181</comments>
            <pubDate>Wed, 12 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317181</guid>        </item>
        <item>
            <title>Epidermal growth factor receptor blockers for the treatment of ovarian cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5302546&amp;cid=c_155168_22_f&amp;fid=38107&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21975775%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: EGFR inhibitors, including pertuzumab, may add activity to conventional chemotherapy for treatment of platinum-resistant ovarian cancer. Certain subsets of women with particularly aggressive tumours resistant to conventional chemotherapy may benefit from EGFR inhibitor treatment. Further RCTs are necessary before EGFR inhibitors are introduced as first- or second-line treatment of ovarian cancer.
    PMID: 21975775 [PubMed - in process] (Source: Cochrane Database of Systematic Reviews)</description>
            <author>Cochrane Database of Systematic Reviews</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5302546</comments>
            <pubDate>Tue, 11 Oct 2011 01:20:04 +0100</pubDate>
            <guid isPermaLink="false">5302546</guid>        </item>
        <item>
            <title>Node-negative T1-T2 anal cancer: Radiotherapy alone or concomitant chemoradiotherapy?</title>
            <link>http://www.medworm.com/index.php?rid=5355423&amp;cid=c_155168_37_f&amp;fid=36282&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21993403%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: In the management of node negative T1-T2 anal cancer, LRC and CSS tend to be superior in patients treated by combined CRT, even though the difference was not significant. Randomized studies are warranted to assess definitively the role of combined treatment in early-stage anal carcinoma.
    PMID: 21993403 [PubMed - as supplied by publisher] (Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology)</description>
            <author>Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5355423</comments>
            <pubDate>Mon, 10 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5355423</guid>        </item>
        <item>
            <title>Copy number aberrations in benign serous ovarian tumors: a case for reclassification?</title>
            <link>http://www.medworm.com/index.php?rid=5346241&amp;cid=c_155168_6_f&amp;fid=38063&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21976534%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Chromosome 12 trisomy has been previously identified in pure fibromas, supporting the concept that a significant proportion of benign serous tumors are primary fibromas with an associated cystic mass. This is the first high resolution genomic analysis of benign serous ovarian tumors and demonstrates not only that the majority of benign serous tumors have no genetic evidence of epithelial neoplasia but that a significant proportion may be more accurately classified as primary fibromas.
    PMID: 21976534 [PubMed - as supplied by publisher] (Source: Clinical Cancer Research)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Clinical Cancer Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5346241</comments>
            <pubDate>Wed, 05 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5346241</guid>        </item>
        <item>
            <title>Interaction between tumour necrosis factor-α gene polymorphisms and substance use on risk of betel quid-related oral and pharyngeal squamous cell carcinoma in Taiwan</title>
            <link>http://www.medworm.com/index.php?rid=5285711&amp;cid=c_155168_11_f&amp;fid=34395&amp;url=http%3A%2F%2Fwww.aobjournal.com%2Farticle%2FPIIS0003996911000896%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: BQ-chewers who carry the G allele or G/G genotype in TNFA −308 may have an increased risk of OPSCC. The intensity of cigarette smoking modulates the effect of the combined TNFA genotypes on risk of BQ-related OPSCC. (Source: Archives of Oral Biology)</description>
            <author>Archives of Oral Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5285711</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5285711</guid>        </item>
        <item>
            <title>Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert’s personal archive</title>
            <link>http://www.medworm.com/index.php?rid=5338831&amp;cid=c_155168_32_f&amp;fid=28438&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2559.2011.03981.x</link>
            <description>Conclusions:  This study shows that: (i) historical material can be still employed usefully, and (ii) the FTH‐phenotype corresponds to a broad spectrum of PTCLs that might form a new category to be validated in future molecular and clinicopathological analyses. (Source: Histopathology)</description>
            <author>Histopathology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5338831</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5338831</guid>        </item>
        <item>
            <title>Comparison of stromal CD10 expression in benign, borderline, and malignant phyllodes tumors among Egyptian female patients.</title>
            <link>http://www.medworm.com/index.php?rid=5591003&amp;cid=c_155168_32_f&amp;fid=37104&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22234101%26dopt%3DAbstract</link>
            <description>Conclusion: From these highly significant results, we believe that there is a strong correlation between CD10 expression and tumor grade, which could be an important observation that may have both diagnostic and prognostic implications as well as promising potential target for development of novel therapies.
    PMID: 22234101 [PubMed - in process] (Source: Indian Journal of Pathology and Microbiology)</description>
            <author>Indian Journal of Pathology and Microbiology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5591003</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5591003</guid>        </item>
        <item>
            <title>Uterine smooth muscle tumors of uncertain malignant potential and atypical leiomyoma: A morphological study of these grey zones with clinical correlation.</title>
            <link>http://www.medworm.com/index.php?rid=5591011&amp;cid=c_155168_32_f&amp;fid=37104&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22234095%26dopt%3DAbstract</link>
            <description>Conclusions: 1) There is an overlap in using the terminologies as STUMP, AL, AL with low risk of recurrence, AL with low malignant potential. A designation of STUMP does convey a category of borderline malignancy to the gynecological surgeons. Most behave in a benign fashion and follow-up without adjuvant therapy is currently recommended. Critical evaluation of coagulative tumor necrosis is essential. Follow-up remains a challenge in our setting.
    PMID: 22234095 [PubMed - in process] (Source: Indian Journal of Pathology and Microbiology)</description>
            <author>Indian Journal of Pathology and Microbiology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5591011</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5591011</guid>        </item>
        <item>
            <title>Epithelial Ovarian Tumors in Adolescents: A Retrospective Pathologic Study and a Critical Review of the Literature</title>
            <link>http://www.medworm.com/index.php?rid=5424010&amp;cid=c_155168_29_f&amp;fid=38523&amp;url=http%3A%2F%2Fwww.jpagonline.org%2Farticle%2FPIIS1083318811003044%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: A relatively high frequency of epithelial ovarian neoplasms among all ovarian tumors in a purely adolescent population was found in our study. Age-related selection bias may account at least in part for the discrepancy between our data and most previous reports. The most common subtype of epithelial ovarian tumor in our series was the benign serous cystadenoma. (Source: Journal of Pediatric and Adolescent Gynecology)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Journal of Pediatric and Adolescent Gynecology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424010</comments>
            <pubDate>Mon, 26 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424010</guid>        </item>
        <item>
            <title>MRI findings of prostate stromal tumour of uncertain malignant potential: a case report.</title>
            <link>http://www.medworm.com/index.php?rid=5251971&amp;cid=c_155168_37_f&amp;fid=37641&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21933974%26dopt%3DAbstract</link>
            <description>Authors: Muglia VF, Saber G, Maggioni G, Monteiro AJ
    Abstract
    Prostatic stromal tumours are rare neoplasias that include benign, malignant and borderline lesions. Stromal tumour of uncertain malignant potential (STUMP) has been recently described and only a few reports exist in the literature. As a rare and distinct neoplasia, to date, there is no description of MRI findings of prostate STUMP. In this article, we describe the clinical and MRI features with histopathological correlation of a patient with prostate STUMP.
    PMID: 21933974 [PubMed - in process] (Source: The British Journal of Radiology)</description>
            <author>The British Journal of Radiology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5251971</comments>
            <pubDate>Mon, 26 Sep 2011 00:39:37 +0100</pubDate>
            <guid isPermaLink="false">5251971</guid>        </item>
        <item>
            <title>Glowing dye 'boosts cancer surgery'</title>
            <link>http://www.medworm.com/index.php?rid=5240119&amp;cid=c_155168_26_f&amp;fid=23300&amp;url=http%3A%2F%2Fwww.nhs.uk%2Fnews%2F2011%2F09September%2FPages%2Fglowing-dye-boosts-tumour-removal.aspx</link>
            <description>Conclusion
This research has illustrated that fluorescent tagging of ovarian cancer cells during diagnostic keyhole surgery is not only possible, but it can also help surgeons identify small areas of cancerous tissue that they cannot see by regular visual inspection alone. This potentially allows surgeons to better identify cancerous tissue when assessing the stage of the cancer by laparoscopy, a technique which is often used alongside other diagnostic imaging procedures such as CT and MRI scanning. It may also help surgeons ensure that they remove all cancerous tissue during therapeutic surgery, which will usually be quite a major operation. In particular, the authors consider that it may guide surgeons when performing debulking surgery, and so improve the likely efficiency of the chemoth...</description>
            <author>NHS News Feed</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5240119</comments>
            <pubDate>Mon, 19 Sep 2011 17:10:00 +0100</pubDate>
            <guid isPermaLink="false">5240119</guid>        </item>
        <item>
            <title>Disseminated tumor cells in pancreatic cancer – an independent prognosticator of disease progression and survival</title>
            <link>http://www.medworm.com/index.php?rid=5236866&amp;cid=c_155168_6_f&amp;fid=33637&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fijc.26439</link>
            <description>AbstractPancreatic cancer is one of the most devastating cancers with a 6‐month median survival and a 5‐year survival rate of 3‐5%. Still important aspects of its aggressive biology remain elusive and advanced therapeutic regimens have not been substantially successful. We investigated the prognostic role of disseminated tumor cells (DTC) in bone marrow, a reservoir for early DTC potentially contributing to metastatic progression, of pancreatic cancer patients. After exclusion of patients with different post‐surgery diagnosis or missing DTC status (n=40) a total of 175 patients remained for final analyses. One‐hundred‐and‐nineteen patients were male and 96 female with a median age of 67 years, 96 patients underwent complete resection. Bone marrow aspirates taken at primary su...</description>
            <author>International Journal of Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5236866</comments>
            <pubDate>Mon, 19 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5236866</guid>        </item>
        <item>
            <title>Disseminated tumor cells in pancreatic cancer—an independent prognosticator of disease progression and survival</title>
            <link>http://www.medworm.com/index.php?rid=5384727&amp;cid=c_155168_6_f&amp;fid=33637&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fijc.26439</link>
            <description>AbstractPancreatic cancer is one of the most devastating cancers with a 6‐month median survival and a 5‐year survival rate of 3–5%. Still important aspects of its aggressive biology remain elusive and advanced therapeutic regimens have not been substantially successful. We investigated the prognostic role of disseminated tumor cells (DTC) in bone marrow, a reservoir for early DTC potentially contributing to metastatic progression, of pancreatic cancer patients. After exclusion of patients with different postsurgery diagnosis or missing DTC status (n = 40) a total of 175 patients remained for final analyses. One‐hundred and nineteen patients were male and 96 female with a median age of 67 years, 96 patients underwent complete resection. Bone marrow aspirates taken at primary surgery...</description>
            <author>International Journal of Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5384727</comments>
            <pubDate>Mon, 19 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5384727</guid>        </item>
        <item>
            <title>The clinicopathological features of intraductal papillary neoplasms of the bile duct in a Chinese population</title>
            <link>http://www.medworm.com/index.php?rid=5667919&amp;cid=c_155168_17_f&amp;fid=35515&amp;url=http%3A%2F%2Fwww.dldjournalonline.com%2Farticle%2FPIIS1590865811003057%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Background: Intraductal papillary neoplasms of the bile duct have been applied to certain types of papillary tumours occurring in the biliary tract. Although many cases have been sporadically reported, there remain controversies.Aims: To analyze the clinicopathologic characteristics and long-term survival of intraductal papillary neoplasms of the bile duct.Methods: The clinicopathologic data of 52 patients who underwent surgery for intraductal papillary neoplasms of the bile duct were retrospectively evaluated.Results: In our series, tumours located in intrahepatic and hilar bile duct, rather than in extrahepatic bile duct, were more commonly diagnosed as adenomas or borderline tumours (12/19 and 7/13 vs 6/20; P=0.046). And the gastric type was more commonly associated with adeno...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Digestive and Liver Disease</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667919</comments>
            <pubDate>Mon, 19 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5667919</guid>        </item>
        <item>
            <title>Surgeons light up cancer cells to cut relapses</title>
            <link>http://www.medworm.com/index.php?rid=5232008&amp;cid=c_155168_58_f&amp;fid=36473&amp;url=http%3A%2F%2Fwww.guardian.co.uk%2Fscience%2F2011%2Fsep%2F18%2Fovarian-cancer-fluorescence-detection</link>
            <description>Doctors believe use of fluorescent dye could boost survival rates by guiding them to tiny clusters of malignant cellsA group of women with ovarian tumours have become the first in the world to have surgery using a procedure that makes cancer light up in the body.Operations were performed on 10 women as part of the first phase of a clinical trial to evaluate the technique, called fluorescence-guided surgery.Doctors developed the procedure to help surgeons remove malignant tissue from ovarian cancer patients and reduce the risk of the disease returning months and years later.The method illuminates cancer cells inside a patient's body to make it easier for surgeons to spot smaller cancers that can be easily missed, and to help them identify the borders between tumours and the healthy tissues ...</description>
            <author>Guardian Unlimited Science</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5232008</comments>
            <pubDate>Sun, 18 Sep 2011 17:00:00 +0100</pubDate>
            <guid isPermaLink="false">5232008</guid>        </item>
        <item>
            <title>Accuracy of frozen section diagnosis of ovarian borderline tumor.</title>
            <link>http://www.medworm.com/index.php?rid=5233772&amp;cid=c_155168_6_f&amp;fid=35590&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21920591%26dopt%3DAbstract</link>
            <description>CONCLUSION: Comprehensive surgical staging can be considered in BT &amp;gt;8cm in diameter, as well as those with micropapillary serous, endometrioid, and clear cell histology diagnosed at the time of frozen section analysis.
    PMID: 21920591 [PubMed - as supplied by publisher] (Source: Gynecologic Oncology)</description>
            <author>Gynecologic Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5233772</comments>
            <pubDate>Tue, 13 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5233772</guid>        </item>
        <item>
            <title>Micropapillary pattern in serous borderline ovarian tumors: Does it matter?</title>
            <link>http://www.medworm.com/index.php?rid=5233777&amp;cid=c_155168_6_f&amp;fid=35590&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21917305%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Because micropapillary SBOT was significantly associated with peritoneal implants, especially invasive implants, and lymph node involvement, complete staging procedures, including lymph node dissection, are recommended. However, micropapillary SBOT itself was not significantly associated with DFS. Peritoneal implant was the only factor independently associated with tumor recurrence.
    PMID: 21917305 [PubMed - as supplied by publisher] (Source: Gynecologic Oncology)</description>
            <author>Gynecologic Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5233777</comments>
            <pubDate>Mon, 12 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5233777</guid>        </item>
        <item>
            <title>Intra-operative frozen section analysis for suspected early-stage ovarian cancer: 11 years of Gateshead Cancer Centre experience.</title>
            <link>http://www.medworm.com/index.php?rid=5199166&amp;cid=c_155168_29_f&amp;fid=34567&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21895958%26dopt%3DAbstract</link>
            <description>Conclusions  Intra-operative FS analysis has excellent diagnostic test accuracy and assists gynaecological oncologists to perform the appropriate surgery in 95% of cases, thereby preventing the morbidity of surgical staging in benign cases and the morbidity of restaging procedures or chemotherapy in early-stage malignant tumours.
    PMID: 21895958 [PubMed - as supplied by publisher] (Source: BJOG : An International Journal of Obstetrics and Gynaecology)</description>
            <author>BJOG : An International Journal of Obstetrics and Gynaecology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5199166</comments>
            <pubDate>Tue, 06 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5199166</guid>        </item>
        <item>
            <title>Intra‐operative frozen section analysis for suspected early‐stage ovarian cancer: 11 years of Gateshead Cancer Centre experience</title>
            <link>http://www.medworm.com/index.php?rid=5198235&amp;cid=c_155168_29_f&amp;fid=32406&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1471-0528.2011.03129.x</link>
            <description>Conclusions  Intra‐operative FS analysis has excellent diagnostic test accuracy and assists gynaecological oncologists to perform the appropriate surgery in 95% of cases, thereby preventing the morbidity of surgical staging in benign cases and the morbidity of restaging procedures or chemotherapy in early‐stage malignant tumours. (Source: BJOG: An International Journal of Obstetrics and Gynaecology)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>BJOG: An International Journal of Obstetrics and Gynaecology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5198235</comments>
            <pubDate>Mon, 05 Sep 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5198235</guid>        </item>
        <item>
            <title>Postoperative respiratory depression with pregabalin: A case series and a preoperative decision algorithm.</title>
            <link>http://www.medworm.com/index.php?rid=5423243&amp;cid=c_155168_5_f&amp;fid=36858&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22059207%26dopt%3DAbstract</link>
            <description>Authors: Eipe N, Penning J
    Abstract
    Pregabalin is gaining popularity in the perioperative period for its usefulness in treating neuropathic pain and its apparent opioid- sparing effect. The present report describes the perioperative course of three patients who received pregabalin and experienced significant respiratory depression in the postoperative period. All three patients consented to the report and publication of the present case series. The first patient was elderly with borderline renal dysfunction. She experienced respiratory arrest in the immediate postoperative period following a craniotomy for tumour excision. The second patient presented with severe respiratory depression 12 h after receiving a spinal anesthetic for joint replacement, and was later found to have clini...</description>
            <author>Pain Research and Management</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5423243</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5423243</guid>        </item>
        <item>
            <title>Aggressive multifocal form of epithelioid hemangioendothelioma--case report.</title>
            <link>http://www.medworm.com/index.php?rid=5575670&amp;cid=c_155168_54_f&amp;fid=38108&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22220455%26dopt%3DAbstract</link>
            <description>Authors: Duletić-Nacinović A, Grohovac D, Dobrila-Dintinjana R, Brncić N, Jonjić N
    Abstract
    Epithelioid hemangioendothelioma (EHE) is a rare tumor of the vascular origin. It was first described in its pulmonary form by Dail and Leibow in 1975 and named &quot;intravascular bronchioalveolar tumor&quot; (IVBAT). Since then, reports of occurrences of the tumor have been made for number of locations, but most often tumor can be found in soft tissues, liver, lungs, bone and skin. It is considered to be a low or borderline malignant tumor with, usually, slow progression, but aggressive forms have been described. We here report a case of a 46-year old female patient with multifocal malignant tumor spreading to lungs, liver, spleen and with synchronous involvement of lumbal vertebrae, illiac bone...</description>
            <author>Collegium Antropologicum</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5575670</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5575670</guid>        </item>
        <item>
            <title>Behavior of Serous Borderline Ovarian Tumors With and Without Micropapillary Patterns: Results of a French Multicenter Study</title>
            <link>http://www.medworm.com/index.php?rid=5183319&amp;cid=c_155168_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fwq34x92h20m4g963%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Patients with MP-SBOT represent a heterogeneous population in terms of presence of invasive peritoneal implants. Conservative
 surgery could be a suitable option for MP-SBOT patients without implants and who wish to conserve childbearing potential,
 without increasing the risk of recurrence.
 
 
 
 
	Content Type Journal ArticleCategory Gynecologic OncologyPages 1-7DOI 10.1245/s10434-011-2039-yAuthors
		R. Fauvet, Department of Gynecology and Obstetrics, University Hospital of Amiens, University of Picardie, Jules Verne, Amiens, FranceE. Demblocque, Department of Gynecology and Obstetrics, University Hospital of Amiens, University of Picardie, Jules Verne, Amiens, FranceP. Morice, Department of Gynecologic Surgery, Gustave Roussy Cancer Institute, University of Paris...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5183319</comments>
            <pubDate>Wed, 31 Aug 2011 05:51:32 +0100</pubDate>
            <guid isPermaLink="false">5183319</guid>        </item>
        <item>
            <title>Neoadjuvant therapy in pancreatic adenocarcinoma: A meta-analysis of phase II trials</title>
            <link>http://www.medworm.com/index.php?rid=5173102&amp;cid=c_155168_43_f&amp;fid=33864&amp;url=http%3A%2F%2Fwww.surgjournal.com%2Farticle%2FPIIS0039606011003576%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Neoadjuvant treatment seems to have some activity in patients with borderline/unresectable pancreatic adenocarcinoma. Nearly one third of tumors initially deemed marginal for operative intervention were able to be ultimately resected after treatment. Until more effective targeted chemotherapeutics are developed, the only group of patients with pancreatic cancer that may benefit from neoadjuvant treatment are those with locally advanced disease. (Source: Surgery)</description>
            <author>Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5173102</comments>
            <pubDate>Mon, 29 Aug 2011 22:07:55 +0100</pubDate>
            <guid isPermaLink="false">5173102</guid>        </item>
        <item>
            <title>Ovarian cancer during pregnancy</title>
            <link>http://www.medworm.com/index.php?rid=5263066&amp;cid=c_155168_29_f&amp;fid=35640&amp;url=http%3A%2F%2Fwww.ijgo.org%2Farticle%2FPIIS0020729211003730%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Early diagnosis and appropriate treatment are crucial for patients with ovarian cancer diagnosed during pregnancy. Tumor staging is possible during pregnancy, but the appropriateness of surgery needs to be considered carefully. Ideally, the treatment strategy should be discussed and structured on an individual basis. (Source: International Journal of Gynaecology and Obstetrics)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>International Journal of Gynaecology and Obstetrics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5263066</comments>
            <pubDate>Mon, 29 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5263066</guid>        </item>
        <item>
            <title>Primary retroperitoneal mucinous cystadenoma of borderline malignancy in a male patient. Case report and review of the literature.</title>
            <link>http://www.medworm.com/index.php?rid=5164040&amp;cid=c_155168_22_f&amp;fid=30439&amp;url=http%3A%2F%2Fwww.wjso.com%2Fcontent%2F9%2F1%2F98</link>
            <description>Conclusion:
This is the third case of primary retroperitoneal mucinous cystadenoma of borderline malignancy in a male patient reported in the literature. The preoperative diagnosis is impossible. Laparotomy constitutes the only diagnostic and curative approach. (Source: BioMed Central)</description>
            <author>BioMed Central</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5164040</comments>
            <pubDate>Fri, 26 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5164040</guid>        </item>
        <item>
            <title>Fine needle aspiration cytology in ovarian lesions: an institutional experience of 584 cases</title>
            <link>http://www.medworm.com/index.php?rid=5164978&amp;cid=c_155168_32_f&amp;fid=28440&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2303.2011.00896.x</link>
            <description>Conclusion:  FNAC has a high specificity for diagnosis of ovarian/adnexal lesions but greater experience is required for the accurate subtyping of neoplasms and sensitivity is limited by inconclusive/inadequate results. (Source: Cytopathology)</description>
            <author>Cytopathology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5164978</comments>
            <pubDate>Wed, 24 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5164978</guid>        </item>
        <item>
            <title>Optimal primary surgical treatment for advanced epithelial ovarian cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5144953&amp;cid=c_155168_22_f&amp;fid=38107&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21833960%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: During primary surgery for advanced stage epithelial ovarian cancer all attempts should be made to achieve complete cytoreduction. When this is not achievable, the surgical goal should be optimal (&amp;lt; 1 cm) residual disease. Due to the high risk of bias in the current evidence, randomised controlled trials should be performed to determine whether it is the surgical intervention or patient-related and disease-related factors that are associated with the improved survival in these groups of women. The findings of this review that women with residual disease &amp;lt; 1 cm still do better than women with residual disease &amp;gt; 1 cm should prompt the surgical community to retain this category and consider re-defining it as 'near optimal' cytoreduction, reserving the term 'suboptimal' c...</description>
            <author>Cochrane Database of Systematic Reviews</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5144953</comments>
            <pubDate>Sat, 20 Aug 2011 17:00:05 +0100</pubDate>
            <guid isPermaLink="false">5144953</guid>        </item>
        <item>
            <title>Phyllodes Tumors: Race-Related Differences</title>
            <link>http://www.medworm.com/index.php?rid=5243865&amp;cid=c_155168_43_f&amp;fid=38538&amp;url=http%3A%2F%2Fwww.journalacs.org%2Farticle%2FPIIS1072751511008982%2Fabstract%3Frss%3Dyes</link>
            <description>Background: Phyllodes tumors (PT) are rare breast malignancies accounting for 0.5% to 1% of all breast tumors. PT have unpredictable behavior, with recurrence rates as high as 40%. A dearth of information exists about racial differences; elucidation of these differences is the objective of this study.Study Design: A retrospective review of patients treated for PT at either Moffitt Cancer Center or University of Texas Health Science Center San Antonio from 1999 to 2010.Results: Of the 124 patients, 71 (57%) were treated at Moffitt Cancer Center and 53 (42%) at University of Texas Health Science Center San Antonio. Mean age at diagnosis was 44 years (15 to 70 years). Thirty-three patients required mastectomy. Combining both cohorts, 42% of the patients were Caucasian, 43% were Hispanic, and ...</description>
            <author>Journal of the American College of Surgeons</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5243865</comments>
            <pubDate>Thu, 18 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5243865</guid>        </item>
        <item>
            <title>Combination of narrow band imaging (NBI) and autofluorescence imaging (AFI) videobronchoscopy in endoscopic assessment of lung cancer extension</title>
            <link>http://www.medworm.com/index.php?rid=5126133&amp;cid=c_155168_6_f&amp;fid=35998&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F34t128374333tr63%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Both narrow band imaging (NBI) and autofluorescence imaging (AFI) are new techniques for the assessment of lung cancer. The
 major aim of this study was to investigate whether the combination of these two techniques improve sensitivity and specificity
 in the assessment of lung cancer extension. The study prospectively evaluated 118 patients with suspected lung cancer. All
 of the patients were examined using EVIS LUCERA SPECTRUM videobronchoscopy system. The narrow band imaging preceded autofluorescence
 imaging examination. In every patient, at least 1 but no more than 4 biopsies were taken from places visualized as pathologic,
 surrounding primary tumor, and at least 1 biopsy from places that appeared visually normal. Sensitivity, specificity, positive,
 and negative...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Medical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5126133</comments>
            <pubDate>Mon, 08 Aug 2011 19:55:34 +0100</pubDate>
            <guid isPermaLink="false">5126133</guid>        </item>
        <item>
            <title>Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy</title>
            <link>http://www.medworm.com/index.php?rid=5633008&amp;cid=c_155168_43_f&amp;fid=34387&amp;url=http%3A%2F%2Fwww.americanjournalofsurgery.com%2Farticle%2FPIIS0002961011003229%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: 
Postoperative mortality and morbidity do not significantly increase after neoadjuvant treatment. Neoadjuvant treatment in locally advanced pancreatic cancer can lead to an objective pathologic response, but this does not significantly improve survival after resection. (Source: American Journal of Surgery)</description>
            <author>American Journal of Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5633008</comments>
            <pubDate>Mon, 08 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5633008</guid>        </item>
        <item>
            <title>[External validation of simple ultrasound rules of Timmerman on 122 ovarian tumors.]</title>
            <link>http://www.medworm.com/index.php?rid=5124512&amp;cid=c_155168_29_f&amp;fid=35591&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21820936%26dopt%3DAbstract</link>
            <description>CONCLUSION: Most adnexal masses can be classified according to the ultrasound simple rules of the score of Timmerman with a good specificity to eliminate their malignant or borderline characteristics. Tumors which cannot be classified according to these rules must be referred to an expert ultrasonographist.
    PMID: 21820936 [PubMed - as supplied by publisher] (Source: Gynecologie, Obstetrique et Fertilite)</description>
            <author>Gynecologie, Obstetrique et Fertilite</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5124512</comments>
            <pubDate>Wed, 03 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5124512</guid>        </item>
        <item>
            <title>Med Sci Monit 2011; 17(8):BR228-234 &amp;quot;RCAS1 expression in mobile tongue squamous cell carcinoma: An immunohistochemical study&amp;quot;</title>
            <link>http://www.medworm.com/index.php?rid=5082836&amp;cid=c_155168_39_f&amp;fid=36926&amp;url=http%3A%2F%2Fwww.medscimonit.com%2Fabstracted.php%3Ficid%3D881902%26level%3D5</link>
            <description>Conclusions:	Our data support evidence for possible implication of RCAS1 at the early stage of tumor progression in mobile tongue SCC, whereas the survival prediction using RCAS1 expression as a clinical marker seems uncertain for this type of malignancy. (Source: Medical Science Monitor)</description>
            <author>Medical Science Monitor</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5082836</comments>
            <pubDate>Mon, 01 Aug 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5082836</guid>        </item>
        <item>
            <title>External validation of the adapted Risk of Malignancy Index incorporating tumor size in the preoperative evaluation of adnexal masses</title>
            <link>http://www.medworm.com/index.php?rid=5450635&amp;cid=c_155168_29_f&amp;fid=35545&amp;url=http%3A%2F%2Fwww.ejog.org%2Farticle%2FPIIS0301211511004568%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Both RMI-3 and RMI-4 were able to discriminate between non-invasive lesions and invasive malignant adnexal masses, with similar performances. Including tumor size in the RMI does not improve its performance. (Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology)</description>
            <author>European Journal of Obstetrics, Gynecology, and Reproductive Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5450635</comments>
            <pubDate>Mon, 01 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5450635</guid>        </item>
        <item>
            <title>Evaluation of Intratumoral HER-2 Heterogeneity by Fluorescence In Situ Hybridization in Invasive Breast Cancer: A Single Institution Study.</title>
            <link>http://www.medworm.com/index.php?rid=5164595&amp;cid=c_155168_22_f&amp;fid=30449&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21860549%26dopt%3DAbstract</link>
            <description>In conclusion, HER-2 gene heterogeneity of invasive breast cancer is identified in routine FISH examination. This may affect the results of HER-2 gene amplification status in FISH studies.
    PMID: 21860549 [PubMed - in process] (Source: J Korean Med Sci)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>J Korean Med Sci</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5164595</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5164595</guid>        </item>
        <item>
            <title>Protein Expressions and Genetic Variations of SLC5A8 in Prostate Cancer Risk and Aggressiveness</title>
            <link>http://www.medworm.com/index.php?rid=5300794&amp;cid=c_155168_47_f&amp;fid=36204&amp;url=http%3A%2F%2Fwww.goldjournal.net%2Farticle%2FPIIS0090429511004936%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: These data suggest that the expression pattern of SLC5A8 might be used as a diagnostic biomarker, and a larger study is required to assess the importance of SLC5A8 single nucleotide polymorphisms in prostate cancer. (Source: Urology)</description>
            <author>Urology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5300794</comments>
            <pubDate>Fri, 29 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5300794</guid>        </item>
        <item>
            <title>Chlamydia trachomatis and Mycoplasma genitalium Plasma Antibodies in Relation to Epithelial Ovarian Tumors</title>
            <link>http://www.medworm.com/index.php?rid=5070747&amp;cid=c_155168_20_f&amp;fid=37030&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fidog%2F2011%2F824627%2F</link>
            <description>Conclusion. Chlamydial HSP60-1 IgG and M. genitalium IgG antibodies are in this study associated with epithelial ovarian tumors in some subsets, which support the hypothesis linking upper-genital tract infections and ovarian tumor development. (Source: Interdisciplinary Perspectives on Infectious Diseases)</description>
            <author>Interdisciplinary Perspectives on Infectious Diseases</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5070747</comments>
            <pubDate>Thu, 28 Jul 2011 13:57:28 +0100</pubDate>
            <guid isPermaLink="false">5070747</guid>        </item>
        <item>
            <title>Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With Pattern of Disease Progression [Gastrointestinal Cancer]</title>
            <link>http://www.medworm.com/index.php?rid=5078570&amp;cid=c_155168_6_f&amp;fid=31124&amp;url=http%3A%2F%2Fjco.ascopubs.org%2Fcgi%2Fcontent%2Fshort%2F29%2F22%2F3037%3Frss%3D1</link>
            <description>Conclusion
This regimen appears effective and has acceptable toxicity. The primary end point (1-year overall survival rate &amp;gt; 45%) was met, with encouraging survival duration. Smad4(Dpc4) immunostaining correlated with the pattern of disease progression. Prospective validation of Smad4(Dpc4) expression in cytology specimens as a predictive biomarker is warranted and may lead to personalized treatment strategies for patients with localized pancreatic cancer. (Source: Journal of Clinical Oncology)</description>
            <author>Journal of Clinical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5078570</comments>
            <pubDate>Wed, 27 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5078570</guid>        </item>
        <item>
            <title>Metastatic urachal carcinoma of the ovary</title>
            <link>http://www.medworm.com/index.php?rid=5072257&amp;cid=c_155168_29_f&amp;fid=32404&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1447-0756.2011.01615.x</link>
            <description>AbstractA 52‐year‐old woman had undergone a partial cystectomy for a cystic mass at the dome of the urinary bladder in 1997. The pathological diagnosis was a urachal mucinous cystadenoma with borderline malignancy. Twelve years later, multiple masses were noted on the uterus, ovaries and abdominal wall. She underwent debulking surgery, including a total hysterectomy, bilateral salpingo‐oophorectomy, pelvic lymph node dissection, infracolic omentectomy, appendectomy, colon mass removal and abdominal wall mass removal. Remnants of the tumor were seeded throughout the abdominal cavity. The pathological evaluation confirmed metastatic urachal mucinous adenocarcinoma in both ovaries, the abdominal wall, the colon mass, the uterosacral ligament and the bladder. Adjuvant chemotherapy with p...</description>
            <author>Journal of Obstetrics and Gynaecology Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5072257</comments>
            <pubDate>Tue, 26 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5072257</guid>        </item>
        <item>
            <title>Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking.</title>
            <link>http://www.medworm.com/index.php?rid=5063689&amp;cid=c_155168_6_f&amp;fid=31083&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21767174%26dopt%3DAbstract</link>
            <description>Conclusion. The IMPT technique produced the most conform plans. For tumors located in the one of the cerebral hemispheres, the non-coplanar RA and the IMPT techniques were able to reduce doses to the contralateral hippocampus. The IMPT technique offered the largest sparing of the brain and fiber tracts. RA techniques tended to produce more conform target doses than IMRT.
    PMID: 21767174 [PubMed - in process] (Source: Acta Oncologica)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Acta Oncologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5063689</comments>
            <pubDate>Tue, 26 Jul 2011 16:02:53 +0100</pubDate>
            <guid isPermaLink="false">5063689</guid>        </item>
        <item>
            <title>Frozen section diagnoses of 578 ovarian tumors made by pathologists with and without expertise on gynecologic pathology.</title>
            <link>http://www.medworm.com/index.php?rid=5061816&amp;cid=c_155168_6_f&amp;fid=35590&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21767870%26dopt%3DAbstract</link>
            <description>CONCLUSION: Intraoperative frozen section diagnosis has a high accuracy rate for ovarian pathologies. Those rates do increase even more if it is evaluated by the Gyn pathologists.
    PMID: 21767870 [PubMed - as supplied by publisher] (Source: Gynecologic Oncology)</description>
            <author>Gynecologic Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5061816</comments>
            <pubDate>Fri, 15 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5061816</guid>        </item>
        <item>
            <title>Oncologic and reproductive outcomes of cystectomy compared with oophorectomy as a treatment for borderline ovarian tumours</title>
            <link>http://www.medworm.com/index.php?rid=5034719&amp;cid=c_155168_56_f&amp;fid=29383&amp;url=http%3A%2F%2Fhumrep.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F26%2F8%2F2008%3Frss%3D1</link>
            <description>CONCLUSIONS
A USO is an appropriate treatment for women with BOTs who wish to preserve fertility. However, a cystectomy is a satisfactory fertility-sparing therapy when a cystectomy is the only surgical option. (Source: Human Reproduction)</description>
            <author>Human Reproduction</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5034719</comments>
            <pubDate>Thu, 14 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5034719</guid>        </item>
        <item>
            <title>Epithelial Ovarian Carcinoma Types and the Coexistence of Ovarian Tumor Conditions</title>
            <link>http://www.medworm.com/index.php?rid=5025650&amp;cid=c_155168_47_f&amp;fid=37021&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fisrn%2Fobgyn%2F2011%2F784919%2F</link>
            <description>Conclusion. One in 
         six patients with a malignant ovarian tumor has 
         a coexisting epithelial tumor condition in the 
         ovary, which is also rather frequently observed 
         in the diagnostic work-up 
         practice. (Source: Advances in Urology)</description>
            <author>Advances in Urology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5025650</comments>
            <pubDate>Thu, 14 Jul 2011 17:39:48 +0100</pubDate>
            <guid isPermaLink="false">5025650</guid>        </item>
        <item>
            <title>Epiregulin as a marker for the initial steps of ovarian cancer development.</title>
            <link>http://www.medworm.com/index.php?rid=5062768&amp;cid=c_155168_6_f&amp;fid=36721&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21769422%26dopt%3DAbstract</link>
            <description>Authors: Amsterdam A, Shezen E, Raanan C, Slilat Y, Ben-Arie A, Prus D, Schreiber L
    Epiregulin (Ep) was found to be produced in non-cancer ovarian cells in response to gonadotropin stimulation as well in ovarian cancer cells in an autonomous manner. However, there were no systematic follow-up studies of Ep expression in the development of different stages of ovarian cancer. Using specific antibodies to Ep and the indirect immunocytochemistry methods, we found that in normal ovary the staining for Ep was mainly confined to the epithelial cells, while the stromal cells were only occasionally and moderately stained. In contrast in benign serous and mucinous tumors most of the tumor cells showed a clear staining in the cytoplasm. In borderline serous and mucinous tumors the staining was mu...</description>
            <author>International Journal of Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5062768</comments>
            <pubDate>Wed, 13 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5062768</guid>        </item>
        <item>
            <title>Prospective randomized controlled study comparing cell block method and conventional smear method for pancreatic juice cytology</title>
            <link>http://www.medworm.com/index.php?rid=5031139&amp;cid=c_155168_17_f&amp;fid=30388&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1443-1661.2011.01180.x</link>
            <description>Conclusions:  The CB method using immunostaining for pancreatic juice cytology showed a much lower rate of equivocal borderline malignancy and a tendency for a higher diagnostic yield compared with smear cytology. Its diagnostic sensitivity, however, was not satisfactory except for pancreatic‐head cancer. (Source: Digestive Endoscopy)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Digestive Endoscopy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5031139</comments>
            <pubDate>Tue, 12 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5031139</guid>        </item>
        <item>
            <title>Neuroendocrine Tumor (Carcinoid) of the Appendix With Mucocele: Sonographic and Pathological Findings</title>
            <link>http://www.medworm.com/index.php?rid=5023560&amp;cid=c_155168_37_f&amp;fid=30470&amp;url=http%3A%2F%2Fjdm.sagepub.com%2Fcgi%2Fcontent%2Fabstract%2F27%2F4%2F176%3Frss%3D1</link>
            <description>Acute right lower quadrant pain is a common emergency department presentation. Medical imaging has a main role to rule out appendicitis. Distinguishing between appendicitis and the other two major appendix pathologies, mucocele and carcinoid tumors, is not easy, but it is important for medical and surgical management planning. Appendix mobility is not usually assessed during sonography, but is it helpful? When comparing sonography and computerized tomography with histopathology findings to distinguish appendiceal pathologies, appendix mobility was found to be a key component. Appendix diameter, wall thickness, hyperemia, and surrounding echogenic fat are signs of an inflammatory process that will fix the appendix. Appendiceal carcinoids and mucoceles, on the other hand, will not initially ...</description>
            <author>Journal of Diagnostic Medical Sonography</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5023560</comments>
            <pubDate>Mon, 11 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5023560</guid>        </item>
        <item>
            <title>Paratubal Borderline Tumor Diagnosed In The Adolescent Period: A Case Report And Review of The Literature</title>
            <link>http://www.medworm.com/index.php?rid=5171509&amp;cid=c_155168_29_f&amp;fid=38523&amp;url=http%3A%2F%2Fwww.jpagonline.org%2Farticle%2FPIIS1083318811002385%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: The evaluation of the structure of cyst by ultrasound and the performance of intraoperative frozen section analysis are two important issues to diagnose the nature of a cyst. Fertility-sparing surgery is the main point of management. (Source: Journal of Pediatric and Adolescent Gynecology)</description>
            <author>Journal of Pediatric and Adolescent Gynecology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5171509</comments>
            <pubDate>Thu, 07 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5171509</guid>        </item>
        <item>
            <title>The Serum CA-125 Concentration Data Assists in Evaluating CT Imaging Information When Used to Differentiate Borderline Ovarian Tumor from Malignant Epithelial Ovarian Tumors.</title>
            <link>http://www.medworm.com/index.php?rid=5146461&amp;cid=c_155168_37_f&amp;fid=30497&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21852906%26dopt%3DAbstract</link>
            <description>CONCLUSION: The serum CA-125 concentration is of additional diagnostic value when used in conjunction with the CT imaging results for differentiating BOTs from MEOTs.
    PMID: 21852906 [PubMed - in process] (Source: Korean J Radiol)</description>
            <author>Korean J Radiol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5146461</comments>
            <pubDate>Thu, 30 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5146461</guid>        </item>
        <item>
            <title>Preoperative Diagnosis of Ductal Carcinoma In Situ Arising Within a Mammary Fibroadenoma: A Case Report</title>
            <link>http://www.medworm.com/index.php?rid=4985418&amp;cid=c_155168_6_f&amp;fid=31098&amp;url=http%3A%2F%2Fjjco.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F41%2F7%2F918%3Frss%3D1</link>
            <description>We present this case to increase awareness of this entity and stress the need for histological evaluation of some breast masses. (Source: Japanese Journal of Clinical Oncology)</description>
            <author>Japanese Journal of Clinical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4985418</comments>
            <pubDate>Wed, 29 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4985418</guid>        </item>
        <item>
            <title>Clinicopathological characteristics of ovarian carcinomas associated with endometriosis</title>
            <link>http://www.medworm.com/index.php?rid=4987728&amp;cid=c_155168_29_f&amp;fid=33465&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk46v14w032k3804j%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;In comparison with common epithelial ovarian cancers, CCC and EACs of the ovary were presented at earlier stages. Cytoreductive
 surgical treatment is critical in order to plan appropriate post-operative management.
 
 
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s00404-011-1957-zAuthors
		A. Kondi-Pafiti, Pathology Laboratory, University of Athens, Athens, GreeceE. Papakonstantinou, 2nd Department of Obstetrics and Gynecology, Aretaieion Hospital, University of Athens, 76 Vas.Sofias Ave, 11528 Athens, GreeceC. Iavazzo, 2nd Department of Obstetrics and Gynecology, Aretaieion Hospital, University of Athens, 76 Vas.Sofias Ave, 11528 Athens, GreeceC. Grigoriadis, 2nd Department of Obstetrics and Gynecology, Aretaieion Hospital, University of Athens, 76 Vas.Sofi...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Archives of Gynecology and Obstetrics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4987728</comments>
            <pubDate>Wed, 29 Jun 2011 10:52:48 +0100</pubDate>
            <guid isPermaLink="false">4987728</guid>        </item>
        <item>
            <title>Stage IA Ovarian Cancers: Comparison of Sonographic Findings and Histopathologic Types Between Patients With Normal and Elevated Serum Cancer Antigen 125 Levels</title>
            <link>http://www.medworm.com/index.php?rid=4964123&amp;cid=c_155168_37_f&amp;fid=39307&amp;url=http%3A%2F%2Fwww.jultrasoundmed.org%2Fcgi%2Fcontent%2Fshort%2F30%2F7%2F943%3Frss%3D1</link>
            <description>Conclusions&amp;mdash;
Stage IA ovarian cancers with normal CA-125 levels tend to be smaller, have less solid components, and have a slightly different distribution of histopathologic types than cancers with elevated CA-125 levels. (Source: Journal of Ultrasound in Medicine)</description>
            <author>Journal of Ultrasound in Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4964123</comments>
            <pubDate>Thu, 23 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4964123</guid>        </item>
        <item>
            <title>Fertility sparing surgery for ovarian tumors in children and young adults</title>
            <link>http://www.medworm.com/index.php?rid=4971831&amp;cid=c_155168_29_f&amp;fid=33465&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp73h332193645367%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Fertility sparing surgery for malignant ovarian tumors in children and young adults has excellent prognosis and should be
 attempted whenever possible.
 
 
 
 
	Content Type Journal ArticlePages 1-3DOI 10.1007/s00404-011-1946-2Authors
		El-Said Abdel-Hady, Department of Obstetrics and Gynecology, Mansoura University, Mansoura, EgyptReda Abdel-Hady Hemida, Department of Obstetrics and Gynecology, Mansoura University, Mansoura, EgyptAnas Gamal, Department of Obstetrics and Gynecology, Mansoura University, Mansoura, EgyptMaged El-Shamey, Department of Obstetrics and Gynecology, Mansoura University, Mansoura, Egypt
	

	
		Journal Archives of Gynecology and ObstetricsOnline ISSN 1432-0711Print ISSN 0932-0067 (Source: Archives of Gynecology and Obstetrics)</description>
            <author>Archives of Gynecology and Obstetrics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971831</comments>
            <pubDate>Thu, 23 Jun 2011 16:28:01 +0100</pubDate>
            <guid isPermaLink="false">4971831</guid>        </item>
        <item>
            <title>Stability of HER2-positive status in breast carcinoma: a comparison between primary and paired metastatic tumors with regard to the possible impact of intervening trastuzumab treatment</title>
            <link>http://www.medworm.com/index.php?rid=4969741&amp;cid=c_155168_6_f&amp;fid=31077&amp;url=http%3A%2F%2Fannonc.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F22%2F7%2F1547%3Frss%3D1</link>
            <description>Conclusions: HER2-positive status remained unchanged in most paired metastases. Loss of HER2-positive status did not seem to be affected by trastuzumab treatment. Differences in testing and interpretation may account for the discordance in some cases. (Source: Annals of Oncology)</description>
            <author>Annals of Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969741</comments>
            <pubDate>Wed, 22 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969741</guid>        </item>
        <item>
            <title>The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas.</title>
            <link>http://www.medworm.com/index.php?rid=5027845&amp;cid=c_155168_32_f&amp;fid=38149&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21738816%26dopt%3DAbstract</link>
            <description>In conclusion, the proliferation markers Ki-67/MIB-1, PHH3, and survivin are positively correlated with each other and with tumor grade, and may contribute in the identification of aggressive ovarian carcinomas.
    PMID: 21738816 [PubMed - in process] (Source: International Journal of Clinical and Experimental Pathology)</description>
            <author>International Journal of Clinical and Experimental Pathology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5027845</comments>
            <pubDate>Sun, 19 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5027845</guid>        </item>
        <item>
            <title>T-staging of rectal cancer: accuracy of 3.0 Tesla MRI compared with 1.5 Tesla</title>
            <link>http://www.medworm.com/index.php?rid=4948334&amp;cid=c_155168_37_f&amp;fid=33259&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff8x23j40q1545163%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;This is the first study to compare 3T with 1.5T MRI for T-staging of rectal cancer within the same patients. Our results showed
 no difference between 3T and 1.5T-MRI for the distinction between T1-2 and borderline T3 tumors, regardless of expertise.
 The higher resolution at 3T-MRI did not aid in the distinction between desmoplasia in T1-2-tumors and tumor stranding in T3-tumors.
 Larger studies are needed to acknowledge these findings.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s00261-011-9770-5Authors
		Monique Maas, Department of Radiology, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ, Maastricht, The NetherlandsDoenja M. J. Lambregts, Department of Radiology, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ, Maastricht,...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Abdominal Imaging</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4948334</comments>
            <pubDate>Wed, 15 Jun 2011 06:21:24 +0100</pubDate>
            <guid isPermaLink="false">4948334</guid>        </item>
        <item>
            <title>Expression of cyclooxygenase-2 (COX-2) and p53 in neighboring invasive and in situ components of breast tumors.</title>
            <link>http://www.medworm.com/index.php?rid=4997463&amp;cid=c_155168_60_f&amp;fid=31704&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21683430%26dopt%3DAbstract</link>
            <description>Authors: Serra KP, Sarian LO, Rodrigues-Peres RM, Vassallo J, Soares FA, Pinto GA, da Cunha IW, Shinzato JY, Derchain SF
    The aim of the study was to assess the relationship between the expression of COX-2 and p53, hormone receptors and HER-2 in the in situ (DCIS) and invasive components of ductal carcinomas (IDC) of the same breast. The expression of COX-2, p53, and hormone receptors was assessed in 87 cases of IDC with contiguous areas of DCIS. Results showed that there was no difference in COX-2 expression comparing the in situ and invasive components of the tumors. In the in situ component, there was a statistically borderline increase in p53 expression in tumors that also expressed COX-2. ER-positive specimens were more common in the group of tumors that expressed COX-2 in the inva...</description>
            <author>Acta Histochemica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4997463</comments>
            <pubDate>Tue, 14 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4997463</guid>        </item>
        <item>
            <title>Robot-Assisted Spleen-Preserving Laparoscopic Distal Pancreatectomy</title>
            <link>http://www.medworm.com/index.php?rid=4936231&amp;cid=c_155168_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F83v6864up3434158%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The unique characteristics of a robotic surgical system were thought to be very helpful during the spleen-preserving laparoscopic
 distal pancreatectomy.2
 –
 6 However, cost is one of the main obstacles for the procedure’s popular clinical practice.2
 
 
 
 
 
	Content Type Journal ArticlePages 1-1DOI 10.1245/s10434-011-1816-yAuthors
		Sung Hoon Choi, Division of Hepatobiliary and Pancreas, Department of Surgery, Yonsei University College of Medicine, Seoul, KoreaChang Moo Kang, Division of Hepatobiliary and Pancreas, Department of Surgery, Yonsei University College of Medicine, Seoul, KoreaWoo Jung Lee, Division of Hepatobiliary and Pancreas, Department of Surgery, Yonsei University College of Medicine, Seoul, KoreaHoon Sang Chi, Division of Hepatobiliary and P...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4936231</comments>
            <pubDate>Sun, 12 Jun 2011 06:04:34 +0100</pubDate>
            <guid isPermaLink="false">4936231</guid>        </item>
        <item>
            <title>Borderline papillary serous tumor of the fimbriated end of the fallopian tube with peritoneal implants</title>
            <link>http://www.medworm.com/index.php?rid=4915829&amp;cid=c_155168_29_f&amp;fid=32404&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1447-0756.2011.01556.x</link>
            <description>AbstractDiagnosis of Borderline papillary serous tumor of the fallopian tube was comprehensively established by Zheng in 1996 supported mostly by a histological similarity to its ovarian counterpart. It is a very rare entity with eight cases published so far and the ninth case described here as a 41‐year‐old woman presented with non‐specific lower abdominal pain, dyspareunia and dysuria. Left adnexal mass was identified and she was operated on. It turned out the tumor was attached exclusively to the left tube, with no connection to any of the surrounding structures and with histology of borderline serous tumor with non‐invasive implants in the left and right ovary and visceral peritoneum. Reviewing available data on genetics of these tumors there was diploid status in one examined ...</description>
            <author>Journal of Obstetrics and Gynaecology Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4915829</comments>
            <pubDate>Wed, 08 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4915829</guid>        </item>
        <item>
            <title>Successful extracorporeal mature oocyte harvesting after laparoscopic oophorectomy following controlled ovarian hyperstimulation for the purpose of fertility preservation in a patient with borderline ovarian tumor</title>
            <link>http://www.medworm.com/index.php?rid=4919123&amp;cid=c_155168_56_f&amp;fid=35981&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fyu521w51824w1837%2F</link>
            <description>Conclusion(s)&amp;nbsp;&amp;nbsp;Mature oocytes were successfully retrieved ex-vivo from the hyperstimulated ovary recovered via laparoscopy. The procedure can be performed in a quick manner, with standard
 equipment, without damaging the ovary, the follicles or the oocytes, and without the risk of cancer cell spillage associated
 with the standard transvaginal oocyte retrieval if there is concern of ovarian surface/peritoneal metastatic disease.
 
 
 
 
	Content Type Journal ArticlePages 1-2DOI 10.1007/s10815-011-9596-7Authors
		Silvina Bocca, The Jones Institute for Reproductive Medicine, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, 605 Colley Ave., Norfolk, VA, USADaynelle Dedmond, Sentara Surgery Specialists, Williamsburg, VA, USAEstella Jones, The Jones Institute ...</description>
            <author>Journal of Assisted Reproduction and Genetics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4919123</comments>
            <pubDate>Wed, 08 Jun 2011 15:46:48 +0100</pubDate>
            <guid isPermaLink="false">4919123</guid>        </item>
        <item>
            <title>Preoperative evaluation of the longitudinal extent of borderline resectable hilar cholangiocarcinoma by intraductal ultrasonography</title>
            <link>http://www.medworm.com/index.php?rid=4904739&amp;cid=c_155168_17_f&amp;fid=30386&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1440-1746.2011.06804.x</link>
            <description>Conclusions: HC staging based on IDUS findings was highly accurate. We therefore highly recommend using IDUS for optimal surgical planning in patients with borderline resectable HC. (Source: Journal of Gastroenterology and Hepatology)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Journal of Gastroenterology and Hepatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4904739</comments>
            <pubDate>Mon, 06 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4904739</guid>        </item>
        <item>
            <title>Alpha-methylacyl-CoA racemase (AMACR) expression in epithelial ovarian cancer</title>
            <link>http://www.medworm.com/index.php?rid=4916070&amp;cid=c_155168_32_f&amp;fid=33280&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk56710g410jx3674%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Alpha-methylacyl-CoA racemase (AMACR) is involved in the cellular metabolism of fatty acids. It is a prognostic factor in
 prostate and colorectal cancer. So far, little is known about its expression and prognostic role in ovarian cancer. We investigated
 the expression of AMACR in a total of 420 ovarian tumors (388 carcinomas, 32 borderline tumors) by immunohistochemistry on
 tissue microarrays of two independent patient cohorts. In both cohorts, cytoplasmic AMACR expression was identified in 11.8%
 (16/136) and 5.4% (13/239), respectively, of the ovarian carcinomas. In contrast, borderline tumors did not show any AMACR
 expression. AMACR expression was significantly associated with histological subtype, FIGO stage, and grade in one cohort and
 low estrogen receptor le...</description>
            <author>Virchows Archiv</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4916070</comments>
            <pubDate>Sat, 04 Jun 2011 06:07:09 +0100</pubDate>
            <guid isPermaLink="false">4916070</guid>        </item>
        <item>
            <title>A pooled analysis of arc-based image-guided simultaneous integrated boost radiation therapy for oligometastatic brain metastases.</title>
            <link>http://www.medworm.com/index.php?rid=4934976&amp;cid=c_155168_37_f&amp;fid=36282&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21641067%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: This pooled analysis has provided robust outcome data regarding the use of arc-based radiotherapy with SIB.
    PMID: 21641067 [PubMed - as supplied by publisher] (Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology)</description>
            <author>Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4934976</comments>
            <pubDate>Wed, 01 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4934976</guid>        </item>
        <item>
            <title>Use of laser-assisted photodynamic therapy for leukoplakia in the larynx</title>
            <link>http://www.medworm.com/index.php?rid=5209813&amp;cid=c_155168_16_f&amp;fid=38696&amp;url=http%3A%2F%2Fwww.optecoto.com%2Farticle%2FPIIS1043181011000030%2Fabstract%3Frss%3Dyes</link>
            <description>Photodynamic therapy is a method for achieving selective tissue destruction of neoplastic and atypical proliferative cells using a chemical photosensitizer, which accumulates within the tumor, and a light source to activate a free radical cascade. This method has been used for a variety of malignant and premalignant conditions. We have been using photodynamic therapy in the larynx for intractable and difficult keratosis with atypia using a nebulized formulation of aminolevulinic acid activated with the 585-nm pulse dye laser (Cynosure, Chelmsford, MA). We can perform this procedure in the office under local anesthesia using a flexible nasopharyngoscope with a 2.5-mm working channel. We have found it to be a valuable adjunct for patients with widespread keratosis and dysplasia. In this arti...</description>
            <author>Operative Techniques in Otolaryngology - Head and Neck Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5209813</comments>
            <pubDate>Wed, 01 Jun 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5209813</guid>        </item>
        <item>
            <title>Lancet seminar: Pancreatic cancer</title>
            <link>http://www.medworm.com/index.php?rid=4873615&amp;cid=c_155168_13_f&amp;fid=38936&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FNews%2F2011---May%2F27%2FLancet-seminar-Pancreatic-cancer%2F</link>
            <description>Source: Lancet
Area: News
 The authors of this article discuss the most common form of pancreatic cancer, pancreatic ductal adenocarcinoma, under the following headings: 
 &amp;nbsp; 
 .&amp;nbsp;Epidemiology .&amp;nbsp;Pathophysiology .&amp;nbsp;Screening to detect curable precursor lesions .&amp;nbsp;Clinical presentation .&amp;nbsp;Diagnosis and staging .&amp;nbsp;Principles of management .&amp;nbsp;Surgery .&amp;nbsp;Pathological findings after surgery .&amp;nbsp;Adjuvant and neoadjuvant treatment .&amp;nbsp;Management of borderline resectable disease .&amp;nbsp;Management of advanced disease .&amp;nbsp;Measurement of tumour response .&amp;nbsp;Investigational treatments for advanced pancreatic cancer .&amp;nbsp;Supportive care (Source: NeLM - News)</description>
            <author>NeLM - News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4873615</comments>
            <pubDate>Thu, 26 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4873615</guid>        </item>
        <item>
            <title>Elevated Plasma Growth Differentiation Factor-15 Correlates with Lymph Node Metastases and Poor Survival in Endometrial Cancer.</title>
            <link>http://www.medworm.com/index.php?rid=4921129&amp;cid=c_155168_6_f&amp;fid=38063&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21616994%26dopt%3DAbstract</link>
            <description>CONCLUSION: Based on findings indicated in a primary investigation set and confirmed in the large secondary validation set, we report for the first time plasma GDF-15 as a biomarker for endometrial cancer phenotype, including presence of lymph node metastasis and reduced survival. Its applicability as predictor of metastatic nodes and in monitoring treatment of endometrial cancer needs to be further studied.
    PMID: 21616994 [PubMed - as supplied by publisher] (Source: Clinical Cancer Research)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Clinical Cancer Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4921129</comments>
            <pubDate>Wed, 25 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4921129</guid>        </item>
        <item>
            <title>Characterization of Papillary Projections in Benign Versus Borderline and Malignant Ovarian Masses on Conventional and Color Doppler Ultrasound</title>
            <link>http://www.medworm.com/index.php?rid=4857496&amp;cid=c_155168_37_f&amp;fid=30478&amp;url=http%3A%2F%2Fwww.ajronline.org%2Fcgi%2Fcontent%2Fabstract%2F196%2F6%2F1444%3Frss%3D1</link>
            <description>CONCLUSION. Association of morphologic and vascular ultrasound findings can highly suggest the diagnosis of benign or malignant papillary projection. (Source: American Journal of Roentgenology)</description>
            <author>American Journal of Roentgenology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4857496</comments>
            <pubDate>Sun, 22 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4857496</guid>        </item>
        <item>
            <title>Breast carcinomas with borderline (2+) HER2 immunohistochemistry: percentage of cells with complete membrane staining for HER2 and the frequency of HER2 amplification</title>
            <link>http://www.medworm.com/index.php?rid=4849244&amp;cid=c_155168_32_f&amp;fid=28429&amp;url=http%3A%2F%2Fjcp.bmj.com%2Fcgi%2Fcontent%2Fshort%2F64%2F6%2F490%3Frss%3D1</link>
            <description>Conclusions
This audit suggests that increasing the threshold for 2+ from 10% to 20% complete membrane staining would reduce the number of in-situ hybridisation tests by 36%, but reduce the detection of amplified tumours by 14%. (Source: Journal of Clinical Pathology)</description>
            <author>Journal of Clinical Pathology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4849244</comments>
            <pubDate>Thu, 19 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4849244</guid>        </item>
        <item>
            <title>Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women</title>
            <link>http://www.medworm.com/index.php?rid=5275985&amp;cid=c_155168_29_f&amp;fid=34385&amp;url=http%3A%2F%2Fwww.ajog.org%2Farticle%2FPIIS0002937811006107%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: HE4 offers superior specificity compared to CA-125 for the differentiation of benign and malignant adnexal masses in premenopausal women. (Source: American Journal of Obstetrics and Gynecology)</description>
            <author>American Journal of Obstetrics and Gynecology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5275985</comments>
            <pubDate>Mon, 16 May 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5275985</guid>        </item>
        <item>
            <title>Laparoendoscopic single-site surgery (LESS) for adnexal tumors: one surgeon's initial experience over a one-year period</title>
            <link>http://www.medworm.com/index.php?rid=5276041&amp;cid=c_155168_29_f&amp;fid=35545&amp;url=http%3A%2F%2Fwww.ejog.org%2Farticle%2FPIIS0301211511002363%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Our results suggest that LESS is a safe and feasible alternative to conventional laparoscopic surgery for the treatment of adnexal tumors. (Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology)</description>
            <author>European Journal of Obstetrics, Gynecology, and Reproductive Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5276041</comments>
            <pubDate>Mon, 16 May 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5276041</guid>        </item>
        <item>
            <title>Keratin 15, transcobalamin I and homeobox gene Hox-B13 expression in breast phyllodes tumors: novel markers in biological classification</title>
            <link>http://www.medworm.com/index.php?rid=4830724&amp;cid=c_155168_6_f&amp;fid=33460&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F956k4vmn75715221%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Breast phyllodes tumors are rare neoplasms which present challenges for histological classification. Microscopic features
 are not always predictive of clinical behavior, and scarce data exist on the prognostic role of biological markers. Our study
 evaluated a series of 145 phyllodes tumors diagnosed at the Department of Pathology, Singapore General Hospital between 2006
 and 2009, incorporating 91 (62.8%) benign, 40 (27.6%) borderline, and 14 (9.7%) malignant phyllodes tumors. Antibodies to
 keratin 15 (KRT15), transcobalamin I (TCN1), and homeobox gene Hox-B13 (HOXB13) were applied to sections cut from tissue microarray
 blocks. KRT15 and TCN1 positivity was defined when there was reactivity of 1% or more stromal cells, while HOXB13 positivity
 was defined using a H-...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Breast Cancer Research and Treatment</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4830724</comments>
            <pubDate>Sat, 14 May 2011 16:02:40 +0100</pubDate>
            <guid isPermaLink="false">4830724</guid>        </item>
        <item>
            <title>The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications</title>
            <link>http://www.medworm.com/index.php?rid=4814694&amp;cid=c_155168_19_f&amp;fid=29474&amp;url=http%3A%2F%2Fbloodjournal.hematologylibrary.org%2Fcgi%2Fcontent%2Fshort%2F117%2F19%2F5019%3Frss%3D1</link>
            <description>The World Health Organization classification of lymphoid neoplasms updated in 2008 represents a worldwide consensus on the diagnosis of these tumors and is based on the recognition of distinct diseases, using a multidisciplinary approach. The updated classification refined the definitions of well-recognized diseases, identified new entities and variants, and incorporated emerging concepts in the understanding of lymphoid neoplasms. However, some questions were unresolved, such as the extent to which specific genetic or molecular alterations define certain tumors, and the status of provisional entities, categories for which the World Health Organization working groups felt there was insufficient evidence to recognize as distinct diseases at this time. In addition, since its publication, new...</description>
            <author>Blood</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4814694</comments>
            <pubDate>Wed, 11 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4814694</guid>        </item>
        <item>
            <title>Histologic, Molecular, and Cytogenetic Features of Ovarian Cancers: Implications for Diagnosis and Treatment [Women's Imaging]</title>
            <link>http://www.medworm.com/index.php?rid=4825131&amp;cid=c_155168_37_f&amp;fid=35338&amp;url=http%3A%2F%2Fradiographics.rsna.org%2Fcgi%2Fcontent%2Fshort%2F31%2F3%2F625%3Frss%3D1</link>
            <description>Ovarian epithelial carcinoma (OEC), the most common ovarian malignancy, is a heterogeneous disease with several histologic subtypes that show characteristic cytogenetic features, molecular signatures, oncologic signaling pathways, and clinical-biologic behavior. Recent advances in histopathology and cytogenetics have provided insights into pathophysiologic features and natural history of OECs. Several studies have shown that high- or low-grade serous, endometrioid, and clear cell carcinomas are characterized by mutations involving the TP53, K-ras/BRAF, CTNNB1, and PIK3CA genes, respectively. High-grade serous carcinomas, the most common subtype, often manifest with early transcoelomic spread of disease beyond the ovaries, whereas low-grade serous and mucinous carcinomas commonly manifest w...</description>
            <author>Radiographics recent issues</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4825131</comments>
            <pubDate>Wed, 11 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4825131</guid>        </item>
        <item>
            <title>Blue Nevi and Related Tumors</title>
            <link>http://www.medworm.com/index.php?rid=4788823&amp;cid=c_155168_166_f&amp;fid=33211&amp;url=http%3A%2F%2Fwww.labmed.theclinics.com%2Farticle%2FPIIS0272271211000321%2Fabstract%3Frss%3Dyes</link>
            <description>This article succinctly describes the common dermal dendritic proliferations and updates readers on newly classified entities and variants. The differential diagnosis of the main entities and strategies to distinguish them from their melanocytic and nonmelanocytic mimics is also presented. (Source: Clinics in Laboratory Medicine)</description>
            <author>Clinics in Laboratory Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4788823</comments>
            <pubDate>Fri, 06 May 2011 06:58:39 +0100</pubDate>
            <guid isPermaLink="false">4788823</guid>        </item>
        <item>
            <title>Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules</title>
            <link>http://www.medworm.com/index.php?rid=4785120&amp;cid=c_155168_37_f&amp;fid=35905&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh353235126462412%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The result of this study indicates that FDG PET/CT can provide additional information for the differentiation between benign
 and malignant IPMNs of the pancreas with mural nodules.
 
 
 
 
	Content Type Journal ArticlePages 1-10DOI 10.1007/s12149-011-0494-yAuthors
		Kentaro Takanami, Department of Radiology, Tohoku University Graduate School of Medicine, Seiryomachi, 1-1 Aoba-ku, Sendai, Miyagi 980-8574, JapanTomomichi Hiraide, Department of Radiology, Tohoku University Graduate School of Medicine, Seiryomachi, 1-1 Aoba-ku, Sendai, Miyagi 980-8574, JapanMasashi Tsuda, Department of Radiology, Tohoku University Graduate School of Medicine, Seiryomachi, 1-1 Aoba-ku, Sendai, Miyagi 980-8574, JapanYasuhiro Nakamura, Department of Pathology, Tohoku University Graduate Sc...</description>
            <author>Annals of Nuclear Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4785120</comments>
            <pubDate>Mon, 02 May 2011 14:59:49 +0100</pubDate>
            <guid isPermaLink="false">4785120</guid>        </item>
        <item>
            <title>Animal‐type melanoma – tumor cell invasion of dermal lymphatics and molecular identification of lymph node metastasis</title>
            <link>http://www.medworm.com/index.php?rid=4776403&amp;cid=c_155168_12_f&amp;fid=31728&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1610-0387.2011.07688.x</link>
            <description>SummaryAnimal‐type melanoma (ATM) represents a rare subtype within the wide spectrum of melanocytic tumors. Clinically, ATM lesions appear as sharply demarcated, brown, black and dark blue pigmented nodules, which show grey‐white surface elements on dermatoscopy. The tumor is restricted to the dermis and arranged in irregular fascicles, which are composed of spindle‐shaped and epithelioid melanocytes. Moderate tumor cell pleomorphism, mitoses and apoptotic cells all suggest a malignant process. Abundant, finely dispersed melanin pigment within tumor cells as well as numerous melanophages are strongly suggestive of ATM. Even though locoregional lymph node metastases are frequently found at diagnosis, the course of ATM is generally benign. Specific molecular changes may be detected in ...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>JDDG</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4776403</comments>
            <pubDate>Sat, 30 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4776403</guid>        </item>
        <item>
            <title>[An ovarian mucinous borderline tumour with mixed mural nodules.]</title>
            <link>http://www.medworm.com/index.php?rid=4775979&amp;cid=c_155168_29_f&amp;fid=36722&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21531088%26dopt%3DAbstract</link>
            <description>We report an additional case of mixed type mural nodules of anaplastic carcinoma and sarcoma-like developed in an ovarian mucinous borderline tumour at a 60-year-old woman.We give details about the classification, the differential diagnosis and prognosis of theses nodules.
    PMID: 21531088 [PubMed - as supplied by publisher] (Source: Journal de Gynecologie, Obstetrique et Biologie de la Reproduction)</description>
            <author>Journal de Gynecologie, Obstetrique et Biologie de la Reproduction</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4775979</comments>
            <pubDate>Wed, 27 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4775979</guid>        </item>
        <item>
            <title>New guidance for ovarian cancer tests</title>
            <link>http://www.medworm.com/index.php?rid=4755656&amp;cid=c_155168_26_f&amp;fid=23300&amp;url=http%3A%2F%2Fwww.nhs.uk%2Fnews%2F2010%2F04April%2FPages%2Fnew-advice-for-testing-for-ovarian-cancer.aspx</link>
            <description>The diagnosis and early treatment of ovarian cancer is in the news today, with the publication of new NICE guidance for doctors on recognising ovarian cancer. NICE calls for more initial investigations (such as a blood test) to take place in GP surgeries - this is so that more women are referred to hospital specialists and begin treatment sooner, greatly increasing their chances of survival.
The guidance focusses on areas where there is current uncertainty or wide variation in clinical practice among doctors with regard to the detection of ovarian cancer, particularly in primary care where most women will present. In particular, the guidance gives clear advice on when to carry out a specific blood test when cancer is suspected.
Dr Fergus Macbeth, Director of the Centre for Clinical Practic...</description>
            <author>NHS News Feed</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4755656</comments>
            <pubDate>Wed, 27 Apr 2011 11:05:00 +0100</pubDate>
            <guid isPermaLink="false">4755656</guid>        </item>
        <item>
            <title>The Influence of Prognostic Factors and Adjuvant Chemoradiation on Survival After Pancreaticoduodenectomy for Ampullary Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=4778704&amp;cid=c_155168_43_f&amp;fid=35987&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy51jq18070056255%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Advanced primary tumor stage and age were associated with inferior OS after PD for AC. Adjuvant therapy did not impact survival.
 Patients with advanced tumor stage should be considered for clinical trials of adjuvant therapy after PD with novel compounds
 and optimized radiation therapy strategies.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s11605-011-1518-6Authors
		Timothy N. Showalter, Department of Radiation Oncology, Jefferson Medical College of Thomas Jefferson University, Kimmel Cancer Center, Philadelphia, PA, USATingting Zhan, Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA, USAP. Rani Anne, Department of Radiation Oncology, Jefferson Medical College of Thomas ...</description>
            <author>Journal of Gastrointestinal Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4778704</comments>
            <pubDate>Wed, 27 Apr 2011 05:47:36 +0100</pubDate>
            <guid isPermaLink="false">4778704</guid>        </item>
        <item>
            <title>NeoGemTax: Gemcitabine and Docetaxel as Neoadjuvant Treatment for Locally Advanced Nonmetastasized Pancreatic Cancer</title>
            <link>http://www.medworm.com/index.php?rid=4778652&amp;cid=c_155168_43_f&amp;fid=33277&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh5l831402623n228%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;NeoGemTax was safe and resection was feasible in a number of patients after systemic neoadjuvant treatment. Further randomized
 clinical trials are needed to identify novel multimodal regimens that would be able to increase the percentage of patients
 undergoing curative pancreatic cancer surgery despite advanced tumor stage at the time of diagnosis.
 
 
 
 
	Content Type Journal ArticlePages 1-10DOI 10.1007/s00268-011-1113-8Authors
		Klaus Sahora, Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, AustriaIrene Kuehrer, Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, AustriaMartin Schindl, Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Aus...</description>
            <author>World Journal of Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4778652</comments>
            <pubDate>Wed, 27 Apr 2011 05:43:28 +0100</pubDate>
            <guid isPermaLink="false">4778652</guid>        </item>
        <item>
            <title>Metabolomic Characterization of Ovarian Epithelial Carcinomas by HRMAS-NMR Spectroscopy</title>
            <link>http://www.medworm.com/index.php?rid=4748858&amp;cid=c_155168_13_f&amp;fid=37036&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fjo%2F2011%2F174019%2F</link>
            <description>Conclusions. Despite the small number of samples used in this study, the results indicate that metabolomic analysis of intact tissues by HRMAS-NMR is a promising technique which might be applicable to the therapeutic management of patients. (Source: Advances in Pharmacological Sciences)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Advances in Pharmacological Sciences</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4748858</comments>
            <pubDate>Tue, 26 Apr 2011 14:23:42 +0100</pubDate>
            <guid isPermaLink="false">4748858</guid>        </item>
        <item>
            <title>Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial</title>
            <link>http://www.medworm.com/index.php?rid=4771730&amp;cid=c_155168_6_f&amp;fid=33460&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F48g085u867254891%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Overexpression of topoisomerase II protein (topo 2α) is postulated to be more closely associated with responsiveness to anthracycline-containing
 chemotherapy than human epidermal growth factor receptor type 2 (HER2) gene amplification or alterations in the topoisomerase
 II alpha gene (TOP2A). The authors used tissue microarrays from 477 of 710 premenopausal women with node-positive breast cancer
 randomized to CEF or CMF adjuvant chemotherapy in the NCIC Clinical Trials Group Mammary 5 (MA.5) trial. No significant interaction
 was found between treatment and continuous topo 2α level in either relapse-free (RFS) or overall survival (OS). In 136 patients
 (28.5%) whose tumors showed topo 2α overexpression by immunohistochemistry based on a cut-off of 13%, CEF was sup...</description>
            <author>Breast Cancer Research and Treatment</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4771730</comments>
            <pubDate>Mon, 25 Apr 2011 16:41:41 +0100</pubDate>
            <guid isPermaLink="false">4771730</guid>        </item>
        <item>
            <title>The first experience of robot assisted spleen-preserving laparoscopic distal pancreatectomy in Korea.</title>
            <link>http://www.medworm.com/index.php?rid=4734860&amp;cid=c_155168_44_f&amp;fid=33195&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21488201%26dopt%3DAbstract</link>
            <description>Authors: Kim DH, Kang CM, Lee WJ, Chi HS
    Spleen-preservation has recently been emphasized in benign and borderline malignant pancreatic diseases requiring distal pancreatectomy. Reports to suggest that laparoscopic distal pancreatectomy is feasible and safe have been increasingly published. Robotic surgical system has been introduced and is expected to provide unique advantages in laparoscopic surgery. However, robot-assisted pancreatic surgery has not yet been performed by many surgeons. A 45-year-old female patient with abdominal discomfort was found to have pancreatic cyst in the body of the pancreas. Mucinous cystic tumor of the pancreas was the most favourable preoperative diagnosis. She underwent spleen-preserving laparoscopic distal pancreatectomy by using da Vinci surgical robo...</description>
            <author>Yonsei Medical Journal</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4734860</comments>
            <pubDate>Thu, 21 Apr 2011 22:00:30 +0100</pubDate>
            <guid isPermaLink="false">4734860</guid>        </item>
        <item>
            <title>Role of Minimally Invasive Surgery in Staging of Ovarian Cancer</title>
            <link>http://www.medworm.com/index.php?rid=4745081&amp;cid=c_155168_6_f&amp;fid=35955&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm383817427412261%2F</link>
            <description>Opinion statement&amp;nbsp;&amp;nbsp;Since the introduction of laparoscopy and robotic surgery in gynecologic practice in the last several decades, use of these
 minimally invasive surgical techniques has increased dramatically. The role of minimally invasive surgical techniques continues
 to expand because they offer reduced intraoperative and postoperative complications, less intraoperative blood loss, and a
 shorter postoperative recovery. Despite initial concerns about the use of minimally invasive surgery in gynecologic oncology,
 this approach has been shown to be safe and effective in the management of uterine and cervical cancer, and minimally invasive
 surgical management of these malignancies is now commonplace. Concerns remain regarding the use of minimally invasive surgery
 for the sta...</description>
            <author>Current Treatment Options in Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4745081</comments>
            <pubDate>Tue, 19 Apr 2011 07:13:29 +0100</pubDate>
            <guid isPermaLink="false">4745081</guid>        </item>
        <item>
            <title>Activation of sonic hedgehog signaling in oral squamous cell carcinomas: a preliminary study</title>
            <link>http://www.medworm.com/index.php?rid=5263410&amp;cid=c_155168_32_f&amp;fid=35623&amp;url=http%3A%2F%2Fwww.humanpathol.com%2Farticle%2FPIIS0046817711000281%2Fabstract%3Frss%3Dyes</link>
            <description>Summary: Sonic hedgehog signaling is important for human development, and aberrant regulation of this pathway can result in the development of tumors. The aim of this study was to examine the expression of sonic hedgehog signaling molecules in oral squamous cell carcinoma. By quantitative real-time polymerase chain reaction, the expression of SHH, SMO, PTCH-1, and GLI-1 was analyzed in 30 oral squamous cell carcinoma cases and 8 samples of nonneoplastic oral mucosa and associated to clinical pathologic features. The expression of β-catenin, cyclin D1, Wnt-1, and Egfr was evaluated by immunohistochemistry in 26 available cases of oral squamous cell carcinoma. Normal oral mucosa from healthy individuals was negative for all genes that were evaluated. SHH, PTCH-1, SMO, and GLI-1 were not exp...</description>
            <author>Human Pathology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5263410</comments>
            <pubDate>Fri, 15 Apr 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5263410</guid>        </item>
        <item>
            <title>Expression of MAGE-A and NY-ESO-1 cancer/testis antigens in medullary breast cancer: retrospective immunohistochemical study.</title>
            <link>http://www.medworm.com/index.php?rid=4724770&amp;cid=c_155168_22_f&amp;fid=30416&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21495200%26dopt%3DAbstract</link>
            <description>Conclusion. Expression of C/T antigens may represent a marker of potential prognostic relevance in MBC.
    PMID: 21495200 [PubMed - in process] (Source: Croatian Medical Journal)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Croatian Medical Journal</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4724770</comments>
            <pubDate>Thu, 14 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4724770</guid>        </item>
        <item>
            <title>Accuracy of frozen section diagnosis of borderline ovarian tumors.</title>
            <link>http://www.medworm.com/index.php?rid=4820155&amp;cid=c_155168_6_f&amp;fid=35590&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21492922%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Frozen section analysis of BOTs has low accuracy, sensitivity, and positive predictive value, and underdiagnosis and overdiagnosis are frequent. Therefore, surgical decision-making for BOTs based on frozen section diagnosis should be done carefully, especially in tumors with mucinous histology.
    PMID: 21492922 [PubMed - as supplied by publisher] (Source: Gynecologic Oncology)</description>
            <author>Gynecologic Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4820155</comments>
            <pubDate>Mon, 11 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4820155</guid>        </item>
        <item>
            <title>Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells</title>
            <link>http://www.medworm.com/index.php?rid=4698012&amp;cid=c_155168_6_f&amp;fid=31136&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fonc%2Frss%2Faop%2F%7E3%2FIsOdU4etOlA%2Fonc.2011.117</link>
            <description>Authors: J-C Cheng, N Auersperg
          &amp; P C K Leung (Source: Oncogene)</description>
            <author>Oncogene</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4698012</comments>
            <pubDate>Sun, 10 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4698012</guid>        </item>
        <item>
            <title>CD34, CD117, and Ki-67 Expression in Phyllodes Tumor of the Breast: An Immunohistochemical Study of 33 Cases</title>
            <link>http://www.medworm.com/index.php?rid=4688694&amp;cid=c_155168_32_f&amp;fid=28428&amp;url=http%3A%2F%2Fijs.sagepub.com%2Fcgi%2Fcontent%2Fabstract%2F19%2F2%2F152%3Frss%3D1</link>
            <description>This study indicates that CD34 and CD117 are differentially expressed in benign and malignant PTs. These markers, therefore, in combination, may be used as an adjunct to morphology in the subclassification of PTs. (Source: International Journal of Surgical Pathology)</description>
            <author>International Journal of Surgical Pathology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4688694</comments>
            <pubDate>Wed, 06 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4688694</guid>        </item>
        <item>
            <title>Mammoplasty for symmetry in breast reconstruction and histologic assessment.</title>
            <link>http://www.medworm.com/index.php?rid=4680869&amp;cid=c_155168_43_f&amp;fid=32941&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21443831%26dopt%3DAbstract</link>
            <description>Conclusion: Systematic histologic analysis of glandular mammary tissue sampled after reduction mammoplasty in the particular context of breast reconstruction after breast cancer makes it possible to discover lesions that were not seen in presurgical evaluation. The early management of these borderline occult lesions could reduce the incidence of breast cancer in these at-risk patients.
    PMID: 21443831 [PubMed - as supplied by publisher] (Source: Canadian Journal of Surgery)</description>
            <author>Canadian Journal of Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4680869</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4680869</guid>        </item>
    </channel>
</rss>

